

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Intracellular targeting with engineered proteins | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/5-1947/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/5-1947" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Intracellular targeting with engineered proteins" />
    
            <meta name="og:title" content="F1000Research Article: Intracellular targeting with engineered proteins.">
            <meta name="og:description" content="Read the latest article version by Shane Miersch, Sachdev S. Sidhu, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="9593">
            <meta name="article-id" content="8915">
            <meta name="dc.title" content="Intracellular targeting with engineered proteins">
            <meta name="dc.description" content="If the isolation, production, and clinical use of insulin marked the inception of the age of biologics as therapeutics, the convergence of molecular biology and combinatorial engineering techniques marked its coming of age. The first wave of recombinant protein-based drugs in the 1980s demonstrated emphatically that proteins could be engineered, formulated, and employed for clinical advantage. Yet despite the successes of protein-based drugs such as antibodies, enzymes, and cytokines, the druggable target space for biologics is currently restricted to targets outside the cell. Insofar as estimates place the number of proteins either secreted or with extracellular domains in the range of 8000 to 9000, this represents only one-third of the proteome and circumscribes the pathways that can be targeted for therapeutic intervention. Clearly, a major objective for this field to reach maturity is to access, interrogate, and modulate the majority of proteins found inside the cell. However, owing to the large size, complex architecture, and general cellular impermeability of existing protein-based drugs, this poses a daunting challenge. In recent years, though, advances on the two related fronts of protein engineering and drug delivery are beginning to bring this goal within reach. First, prompted by the restrictions that limit the applicability of antibodies, intense efforts have been applied to identifying and engineering smaller alternative protein scaffolds for the modulation of intracellular targets. In parallel, innovative solutions for delivering proteins to the intracellular space while maintaining their stability and functional activity have begun to yield successes. This review provides an overview of bioactive intrabodies and alternative protein scaffolds amenable to engineering for intracellular targeting and also outlines advances in protein engineering and formulation for delivery of functional proteins to the interior of the cell to achieve therapeutic action.">
            <meta name="dc.subject" content="proteins, intracellular targeting, protein interactions, ">
            <meta name="dc.creator" content="Miersch, Shane">
            <meta name="dc.creator" content="Sidhu, Sachdev S.">
            <meta name="dc.date" content="2016/08/10">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.8915.1">
            <meta name="dc.source" content="F1000Research 2016 5:1947">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="proteins ">
            <meta name="prism.keyword" content=" intracellular targeting ">
            <meta name="prism.keyword" content=" protein interactions ">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2016/08/10">
            <meta name="prism.volume" content="5">
            <meta name="prism.number" content="1947">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.8915.1">
            <meta name="prism.url" content="https://f1000research.com/articles/5-1947">
            <meta name="citation_title" content="Intracellular targeting with engineered proteins">
            <meta name="citation_abstract" content="If the isolation, production, and clinical use of insulin marked the inception of the age of biologics as therapeutics, the convergence of molecular biology and combinatorial engineering techniques marked its coming of age. The first wave of recombinant protein-based drugs in the 1980s demonstrated emphatically that proteins could be engineered, formulated, and employed for clinical advantage. Yet despite the successes of protein-based drugs such as antibodies, enzymes, and cytokines, the druggable target space for biologics is currently restricted to targets outside the cell. Insofar as estimates place the number of proteins either secreted or with extracellular domains in the range of 8000 to 9000, this represents only one-third of the proteome and circumscribes the pathways that can be targeted for therapeutic intervention. Clearly, a major objective for this field to reach maturity is to access, interrogate, and modulate the majority of proteins found inside the cell. However, owing to the large size, complex architecture, and general cellular impermeability of existing protein-based drugs, this poses a daunting challenge. In recent years, though, advances on the two related fronts of protein engineering and drug delivery are beginning to bring this goal within reach. First, prompted by the restrictions that limit the applicability of antibodies, intense efforts have been applied to identifying and engineering smaller alternative protein scaffolds for the modulation of intracellular targets. In parallel, innovative solutions for delivering proteins to the intracellular space while maintaining their stability and functional activity have begun to yield successes. This review provides an overview of bioactive intrabodies and alternative protein scaffolds amenable to engineering for intracellular targeting and also outlines advances in protein engineering and formulation for delivery of functional proteins to the interior of the cell to achieve therapeutic action.">
            <meta name="citation_description" content="If the isolation, production, and clinical use of insulin marked the inception of the age of biologics as therapeutics, the convergence of molecular biology and combinatorial engineering techniques marked its coming of age. The first wave of recombinant protein-based drugs in the 1980s demonstrated emphatically that proteins could be engineered, formulated, and employed for clinical advantage. Yet despite the successes of protein-based drugs such as antibodies, enzymes, and cytokines, the druggable target space for biologics is currently restricted to targets outside the cell. Insofar as estimates place the number of proteins either secreted or with extracellular domains in the range of 8000 to 9000, this represents only one-third of the proteome and circumscribes the pathways that can be targeted for therapeutic intervention. Clearly, a major objective for this field to reach maturity is to access, interrogate, and modulate the majority of proteins found inside the cell. However, owing to the large size, complex architecture, and general cellular impermeability of existing protein-based drugs, this poses a daunting challenge. In recent years, though, advances on the two related fronts of protein engineering and drug delivery are beginning to bring this goal within reach. First, prompted by the restrictions that limit the applicability of antibodies, intense efforts have been applied to identifying and engineering smaller alternative protein scaffolds for the modulation of intracellular targets. In parallel, innovative solutions for delivering proteins to the intracellular space while maintaining their stability and functional activity have begun to yield successes. This review provides an overview of bioactive intrabodies and alternative protein scaffolds amenable to engineering for intracellular targeting and also outlines advances in protein engineering and formulation for delivery of functional proteins to the interior of the cell to achieve therapeutic action.">
            <meta name="citation_keywords" content="proteins, intracellular targeting, protein interactions, ">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Shane Miersch">
            <meta name="citation_author_institution" content="Banting and Best Department of Medical Research, Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, Ontario, Canada">
            <meta name="citation_author" content="Sachdev S. Sidhu">
            <meta name="citation_author_institution" content="Banting and Best Department of Medical Research, Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, Ontario, Canada">
            <meta name="citation_publication_date" content="2016/08/10">
            <meta name="citation_volume" content="5">
            <meta name="citation_publication_number" content="1947">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.8915.1">
            <meta name="citation_firstpage" content="1947">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/5-1947/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/5-1947.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=9593 /> <input type=hidden id=articleId name=articleId value=8915 /> <input type=hidden id=xmlUrl value="/articles/5-1947/v1/xml"/> <input type=hidden id=xmlFileName value="-5-1947-v1.xml"> <input type=hidden id=article_uuid value=f4d4189a-2e0b-42dd-a942-5c4ae6e6ba25 /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Intracellular targeting with engineered proteins"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.8915.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.8915.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/5-1947"
  },
  "headline": "Intracellular targeting with engineered proteins",
  "datePublished": "2016-08-10T15:10:37",
  "dateModified": "2016-08-10T15:10:37",
  "author": [
    {
      "@type": "Person",
      "name": "Shane Miersch"
    },    {
      "@type": "Person",
      "name": "Sachdev S. Sidhu"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "If the isolation, production, and clinical use of insulin marked the inception of the age of biologics as therapeutics, the convergence of molecular biology and combinatorial engineering techniques marked its coming of age. The first wave of recombinant protein-based drugs in the 1980s demonstrated emphatically that proteins could be engineered, formulated, and employed for clinical advantage. Yet despite the successes of protein-based drugs such as antibodies, enzymes, and cytokines, the druggable target space for biologics is currently restricted to targets outside the cell. Insofar as estimates place the number of proteins either secreted or with extracellular domains in the range of 8000 to 9000, this represents only one-third of the proteome and circumscribes the pathways that can be targeted for therapeutic intervention. Clearly, a major objective for this field to reach maturity is to access, interrogate, and modulate the majority of proteins found inside the cell. However, owing to the large size, complex architecture, and general cellular impermeability of existing protein-based drugs, this poses a daunting challenge. In recent years, though, advances on the two related fronts of protein engineering and drug delivery are beginning to bring this goal within reach. First, prompted by the restrictions that limit the applicability of antibodies, intense efforts have been applied to identifying and engineering smaller alternative protein scaffolds for the modulation of intracellular targets. In parallel, innovative solutions for delivering proteins to the intracellular space while maintaining their stability and functional activity have begun to yield successes. This review provides an overview of bioactive intrabodies and alternative protein scaffolds amenable to engineering for intracellular targeting and also outlines advances in protein engineering and formulation for delivery of functional proteins to the interior of the cell to achieve therapeutic action."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/5-1947",
            "name": "Intracellular targeting with engineered proteins"
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Intracellular targeting with engineered proteins </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=9593 data-id=8915 data-downloads="" data-views="" data-scholar="10.12688/f1000research.8915.1" data-recommended="" data-doi="10.12688/f1000research.8915.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/5-1947/v1/pdf?article_uuid=f4d4189a-2e0b-42dd-a942-5c4ae6e6ba25" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-8915-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-8915-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-8915-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Miersch S and Sidhu SS. Intracellular targeting with engineered proteins [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2016, <b>5</b>(F1000 Faculty Rev):1947 (<a class=new-orange href="https://doi.org/10.12688/f1000research.8915.1" target=_blank>https://doi.org/10.12688/f1000research.8915.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-8915-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=8915 id=track-article-signin-8915 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/8915?target=/articles/5-1947">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=9593 /> <input name=articleId type=hidden value=8915 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Intracellular targeting with engineered proteins</h1><span class=other-info> [version 1; peer review: 2 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class=""><a href="mailto:shanemiersch@gmail.com" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Shane Miersch</span></a>,&nbsp;</span><span class=""><a href="mailto:sachdev.sidhu@utoronto.ca" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Sachdev S. Sidhu</span></a></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class=""><a href="mailto:shanemiersch@gmail.com" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Shane Miersch</span></a>,&nbsp;</span><span class=""><a href="mailto:sachdev.sidhu@utoronto.ca" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Sachdev S. Sidhu</span></a></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 10 Aug 2016 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.8915.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> Banting and Best Department of Medical Research, Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, Ontario, Canada<br/> <p> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=15636-14982></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=15637-14981></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> If the isolation, production, and clinical use of insulin marked the inception of the age of biologics as therapeutics, the convergence of molecular biology and combinatorial engineering techniques marked its coming of age. The first wave of recombinant protein-based drugs in the 1980s demonstrated emphatically that proteins could be engineered, formulated, and employed for clinical advantage. Yet despite the successes of protein-based drugs such as antibodies, enzymes, and cytokines, the druggable target space for biologics is currently restricted to targets outside the cell. Insofar as estimates place the number of proteins either secreted or with extracellular domains in the range of 8000 to 9000, this represents only one-third of the proteome and circumscribes the pathways that can be targeted for therapeutic intervention. Clearly, a major objective for this field to reach maturity is to access, interrogate, and modulate the majority of proteins found inside the cell. However, owing to the large size, complex architecture, and general cellular impermeability of existing protein-based drugs, this poses a daunting challenge. In recent years, though, advances on the two related fronts of protein engineering and drug delivery are beginning to bring this goal within reach. First, prompted by the restrictions that limit the applicability of antibodies, intense efforts have been applied to identifying and engineering smaller alternative protein scaffolds for the modulation of intracellular targets. In parallel, innovative solutions for delivering proteins to the intracellular space while maintaining their stability and functional activity have begun to yield successes. This review provides an overview of bioactive intrabodies and alternative protein scaffolds amenable to engineering for intracellular targeting and also outlines advances in protein engineering and formulation for delivery of functional proteins to the interior of the cell to achieve therapeutic action. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> proteins, intracellular targeting, protein interactions, </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Shane Miersch (<a href="mailto:shanemiersch@gmail.com">shanemiersch@gmail.com</a>) <br> Sachdev S. Sidhu (<a href="mailto:sachdev.sidhu@utoronto.ca">sachdev.sidhu@utoronto.ca</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding authors:</b> Shane Miersch, Sachdev S. Sidhu </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> The authors declare that they have no competing interests. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> The author(s) declared that no grants were involved in supporting this work. </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp; © 2016 Miersch S and Sidhu SS. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Miersch S and Sidhu SS. Intracellular targeting with engineered proteins [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2016, <b>5</b>(F1000 Faculty Rev):1947 (<a href="https://doi.org/10.12688/f1000research.8915.1" target=_blank>https://doi.org/10.12688/f1000research.8915.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 10 Aug 2016, <b>5</b>(F1000 Faculty Rev):1947 (<a href="https://doi.org/10.12688/f1000research.8915.1" target=_blank>https://doi.org/10.12688/f1000research.8915.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 10 Aug 2016, <b>5</b>(F1000 Faculty Rev):1947 (<a href="https://doi.org/10.12688/f1000research.8915.1" target=_blank>https://doi.org/10.12688/f1000research.8915.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d85322e163>Introduction</h2><p class="" id=d85322e166>Proteins transmit signals that mediate cellular function and dysfunction in part via assembly into complexes with other proteins through binding interfaces responsible for transient or enduring interactions. These sites of protein-protein interaction represent a class of drug targets that allow cell signals to be modulated. Interaction interfaces have been probed extensively and have been revealed to assume both gross planar or curved topologies with complex localized surfaces<sup><a href="#ref-1">1</a></sup>. Their areas tend to range from about 1000 to 2000 Å<sup>2</sup> (with some much larger) and tend to possess a higher proportion of hydrophobic residues than the exposed protein surface<sup><a href="#ref-2">2</a>–<a href="#ref-4">4</a></sup>. As a result of the large surfaces and number of weak bonds that collectively give rise to affinity between proteins, small molecules have largely been less effective in disrupting protein complexes and tend rather to target hydrophobic pockets or clefts<sup><a href="#ref-5">5</a></sup>. Estimates of the number of proteins that possess functional dependence on such structural features, or the small-molecule “druggable” portion of the proteome, suggest this to encompass only about 10% of the entire complement of human proteins<sup><a href="#ref-6">6</a></sup>. As a result, protein-protein interactions thought to be undruggable or high-risk targets using conventional small molecules, through herculean efforts, have rendered some interactions druggable<sup><a href="#ref-7">7</a></sup>. Nevertheless, owing to their small size and a relative paucity of interactions, targeting with small molecules can also lead to issues with specificity and off-target effects that undermine their pharmacological profile.</p><p class="" id=d85322e196>Alternately, owing to their increased size and propensity for electrostatic and geometric complementarity, protein-based drugs such as antibodies are generally better suited to disruption of the large, flatter but topologically complex surfaces that comprise sites of protein-protein interactions (although camelids and V<sub>H</sub> domains may expand the scope of accessible targets because of their observed ability to bind surface clefts<sup><a href="#ref-8">8</a>,<a href="#ref-9">9</a></sup>) and are less prone to off-target effects. In the extracellular space, antibodies have proven to be a versatile means for targeting and modifying the activities of proteins. They have consequently altered the therapeutic landscape and now constitute the dominant class of new pharmaceuticals<sup><a href="#ref-10">10</a></sup>. Advances in display technologies, means of generating combinatorial libraries, and an expanding repertoire of non-antibody scaffolds continue to revolutionize the field of protein engineering and move towards the clinic in support of a burgeoning biologics-based pharmaceutical industry<sup><a href="#ref-11">11</a>,<a href="#ref-12">12</a></sup>. Currently, a broad variety of scaffold topologies are under development for drug applications and ensure that complementary binding agents should be available for the similarly broad array of target surfaces.</p><p class="" id=d85322e220>The delivery of protein-based drugs directly to the cell interior represents perhaps the last major hurdle in accessing the vast array of protein-protein interactions inside the cell that are not currently amenable to targeting by small-molecule drugs. Historically, protein modulation inside the cell has been accomplished indirectly by expressing ectopic proteins encoded by DNA delivered into the cell or through disruption of protein expression by using RNA interference. Despite the utility of these approaches, a host of drawbacks largely preclude their use as a means of therapeutic intervention (discussed below). Alternately, direct protein transduction could replace dysfunctional proteins without the need for expression, enable the use of non-canonical amino acid residues in therapeutics, and make possible direct modulation of target proteins, post-translationally modified proteins, and conformational variants that, though potentially targeted by genetic methods (that is, via direct expression from encoding constructs), could further enhance control over intracellular therapeutic concentrations.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d85322e226>Proteins engineered to target and modulate intracellular proteins</h2><p class="" id=d85322e229>There are many examples in which intracellular protein function (that is, nuclear, cytoplasmic, mitochondrial, lysosomal, endoplasmic reticulum, and so on) is at the root of disorders, including oncogenic, autoimmune, and degenerative diseases<sup><a href="#ref-13">13</a>–<a href="#ref-15">15</a></sup>. These proteins include modulators of gene expression, cell cycle progression, protein folding and apoptosis, novel chimeric products of gene translocations, oncogenic proteins, and many more, and they offer a rich and vast trove of potential targets for therapeutic intervention.</p><p class="" id=d85322e239>Antibodies have been highly effective in targeting cell surface proteins involved in disease development. Though it is generally believed that their large size, complex architecture, and structural reliance on disulfide bonds preclude intracellular application, a number of examples of both <i>in situ</i>-expressed<sup><a href="#ref-16">16</a></sup> and exogenously supplied whole antibodies<sup><a href="#ref-15">15</a>–<a href="#ref-20">20</a></sup> shown to maintain functional intracellular activity exist in the literature. Attempts to use smaller, less complex binding proteins such as antigen-binding fragments (Fabs) and single-chain variable fragments (scFvs) for intracellular application have similarly shown success in their ability to bind and modulate cytoplasmic protein function<sup><a href="#ref-18">18</a>–<a href="#ref-21">21</a></sup>. However, they can be susceptible to disulfide bond reduction, and aggregation of <i>in situ-</i>expressed antibody fragments is a common occurrence in the reducing environment of the cytoplasm<sup><a href="#ref-23">23</a>–<a href="#ref-26">26</a></sup>. To circumvent these issues, investigators have developed novel engineering and selection strategies that seek to (a) identify minimal binding frameworks<sup><a href="#ref-22">22</a>,<a href="#ref-23">23</a></sup>, (b) increase stability<sup><a href="#ref-24">24</a>–<a href="#ref-27">27</a></sup>, (c) eliminate reliance on disulfide bonds<sup><a href="#ref-22">22</a>,<a href="#ref-23">23</a></sup>, and (d) identify validated functional binding intrabodies<sup><a href="#ref-28">28</a>–<a href="#ref-30">30</a></sup>. These efforts have been complemented by additional studies confirming the delivery and retention of <i>in situ</i>-expressed intrabodies in specific subcellular compartments (nuclear, cytoplasmic, endoplasmic reticular, and peroxisomal) by fusing them to signal sequences to promote interaction with sequestered target proteins<sup><a href="#ref-31">31</a>–<a href="#ref-33">33</a></sup>. In addition, the growing number of proteins effectively targeted by intrabodies suggests ongoing interest in their future role as potential therapeutic agents for mitigation of disease<sup><a href="#ref-33">33</a>–<a href="#ref-37">37</a></sup>.</p><p class="" id=d85322e320>The number of novel, domain-sized proteins demonstrated as affinity agents that can be engineered for specificity is also growing. These scaffolds are finding increasing application because of their small size, lack of cysteines, and stable folding, and the wide array of topologies shown to be amenable to engineering ensures the availability of potentially complementary binding agents to virtually any target<sup><a href="#ref-12">12</a>,<a href="#ref-38">38</a></sup>. Most of these are currently under development for extracellular applications; however, several notable intracellular applications under development warrant discussion.</p><p class="" id=d85322e330>A general approach has recently been described to develop reagents, probes, and potential therapeutics against the enzymes of the ubiquitin system<sup><a href="#ref-39">39</a></sup>. Post-translational ubiquitination of proteins is a mode of signal transduction used pervasively inside the cell to regulate numerous critical cellular functions<sup><a href="#ref-41">41</a>,<a href="#ref-42">42</a></sup>. The large, solvent-accessible surface of ubiquitin that mediates low-affinity interactions with a variety of proteins was recognized as being amenable to engineering, and the surface was randomized in combinatorial libraries to isolate high-affinity variants with selectivity for enzymes of the ubiquitin cascade. In a series of studies, novel variants based on the ubiquitin scaffold were developed as tools to probe the various ubiquitinating (E1, E2, and E3) ligases, deubiquitinases (DUBs), and ubiquitin-binding domains<sup><a href="#ref-39">39</a>–<a href="#ref-41">41</a></sup>. By isolating a series of high-affinity ubiquitin variants (Ubvs) to numerous DUBs<sup><a href="#ref-32">32</a></sup>, HECT E3 ligases<sup><a href="#ref-39">39</a>,<a href="#ref-41">41</a></sup>, and SCF E3 ligases<sup><a href="#ref-40">40</a></sup> that were capable of either antagonizing or agonizing the activity of its target both <i>in vitro</i> and in a cellular milieu, a path for addressing the knowledge lag on ubiquitination signaling versus other major pathways (for example, phosphorylation/dephosphorylation) has been established. To underscore the utility of Ubvs in probing enzyme cascades, investigators confirmed Ubv expression and interactions with intracellular targets by co-immunoprecipitation, observed expected changes in the ubiquitination and stability of ligase or DUB targets, and characterized downstream signals modulated by variants<sup><a href="#ref-39">39</a>–<a href="#ref-41">41</a></sup>. Taken together, these studies not only provide a foundation for continued inquiry into and characterization of ubiquitin signaling pathways but also lay the groundwork for therapeutic intervention in which dysfunction of ubiquitin cascades is at the root of disease.</p><p class="" id=d85322e378>Monobodies derived from the tenth type III domain of human fibronectin (FN3) have been widely used for a variety of extracellular applications<sup><a href="#ref-42">42</a></sup>, and some variants are under clinical evaluation<sup><a href="#ref-43">43</a></sup>. Their appeal stems in part from a lack of disulfide bonds and a stable structure resembling an immunoglobulin fold with six loops (three at either end of the molecule), five of which can be randomized without excessive destabilization. Selections against the SH3 domain of Fyn using phage-displayed combinatorial libraries based on the FN3 scaffold yielded a variant that binds to several family members (but not to closely related kinases) in a neutral fashion (that is, does not modify enzyme activity or interactions) but bears sensitivity to the conformational state of the target. Activation of Src is known to relieve intramolecular bonds within the SH3 domain that enables auto-phosphorylation. Though selected variants did not influence the kinase activity of Src, they did appear to exhibit selectivity for an active, open conformation in immunoprecipitation assays conducted in the presence or absence of the Src kinase activator ciglitazone. This enabled the use of fluorogenically tagged analogs of the binding variant to image SFK activation at the leading edges of cells as an increase in fluorescence upon target binding following microinjection into cells. This provides a prescient example that could illuminate the engineering of therapeutic biological agents that target disease-associated protein conformations to provide enhanced specificity<sup><a href="#ref-44">44</a></sup>.</p><p class="" id=d85322e393>Another valuable demonstration of the utility of non-antibody affinity scaffolds against intracellular proteins involved selective targeting of post-translational phosphor-modifications on the mitogen-activated protein kinase (MAPK) family member extracellular signal-regulated kinase 2 (ERK2). The designed ankyrin repeat protein (DARPin) scaffold was used to isolate binders to the phosphorylated and non-phosphorylated forms of ERK2<sup><a href="#ref-45">45</a></sup>. The DARPin framework is composed of a series of repeating 3.5 kDa modules with both invariant framework regions and potential binding surface residues amenable to randomization. Four-module DARPins (14 kDa) targeting either of the two forms of ERK2 were used in a bioluminescence resonance energy transfer (BRET) assay to provide evidence of intracellular target binding. Serum stimulation of cells resulted in a loss of signal for the unphosphorylated ERK2 and an increase in signal for the phosphorylated form. Alternately, treatment with the ERK pathway inhibitor PD98509 resulted in an increase in signal for native ERK2 and a loss in the phosphor-signal despite no overall changes in ERK2 levels. Though the investigators did not explore the consequences of binding on downstream elements of the signaling cascade, these results suggest that DARPins could modify ERK2 signals in a manner that could offer therapeutic value given their role in inflammation, apoptosis, and oncogenic transformation.</p><p class="" id=d85322e400>In addition to binders against a variety of extracellular targets, affibodies, based on a tri-helical bundle derived from the Z domain of <i>Staphylococcus aureus</i>, have been selected against two intracellular members of the MAPK pathway: H-Ras and Raf-1<sup><a href="#ref-46">46</a></sup>. Binding variants with high-nanomolar to low-micromolar affinity were either indirectly expressed from encoding constructs or directly transduced using a cell-penetrating peptide (CPP) transfection reagent. With either approach, partial inhibition of tumor necrosis factor-alpha in a synovial cell line induced secretion of the inflammatory mediators interleukin-6 and prostaglandin E<sub>2</sub><sup><a href="#ref-47">47</a></sup>. However, inhibition of proliferation was observed only with directly transduced protein and in general produced a greater degree of inhibition of inflammatory mediators than the ectopically expressed variants, suggesting that more protein is delivered via transduction than transfection. Although neither form resulted in potent inhibition, this may be more related to their modest affinities rather than a mechanistic limitation. These examples not only serve as state-of-the-art demonstrations of engineering for intracellular protein targeting but also lay the foundations for future efforts aimed at using engineered proteins in therapeutic applications (<a href="#f1">Figure 1</a>).</p><div class="fig panel clearfix"><a name=f1 class=n-a></a><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/9593/f71c1e78-bcee-4eed-a790-aae843012f87_figure1.gif"><img alt="f71c1e78-bcee-4eed-a790-aae843012f87_figure1.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/9593/f71c1e78-bcee-4eed-a790-aae843012f87_figure1.gif"></a><div class=caption><h3>Figure 1. Alternative scaffolds used for the modulation of intracellular protein targets.</h3><p id=d85322e429>The main chains of non-antibody scaffolds used to generate variants against intracellular targets are rendered in purple, and residues of the binding surface known to tolerate randomization are depicted as blue spheres. Structures in complex with intracellular target proteins (grey ribbons) are shown below. No structures exist for affibodies bound to intracellular targets and thus the structure of an affibody bound to the extracellular domain of HER2 is shown.</p></div></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d85322e439>Intracellular delivery of proteins</h2><p class="" id=d85322e442>To date, the vast majority of therapeutics targeting intracellular proteins are small molecules, which, owing to their small size and amphiphilic properties, can partition into and pass through cell membranes. In stark contrast, the most daunting challenge to the use of protein-based therapeutics for targeting of intracellular macromolecules is the fact that most proteins do not cross hydrophobic membranes efficiently.</p><p class="" id=d85322e445>For research, the delivery of proteins intended to modulate the function of intracellular protein activity is most often accomplished by transfection of DNA encoding either native or engineered proteins, which enables endogenous transcriptional and translational machinery to express them ectopically<sup><a href="#ref-48">48</a></sup>. Though the delivery of proteins can be effective <i>in vitro</i>, challenges with systemic delivery, poor efficiency of delivery, toxicity<sup><a href="#ref-49">49</a></sup>, and additional layers of transcriptional and translational regulation make the goal of controlled protein expression for therapeutic application highly challenging. Viruses have been extensively explored for gene therapy, and ways of co-opting their ability to inject genetic cargo inside the cell have been devised for protein delivery<sup><a href="#ref-50">50</a></sup>. However, issues associated with viral delivery—including immunogenicity, inflammation and cytotoxicity, a lack of precise control over expression levels (and thus dosing), and complications associated with genetic integration during stable transfection (for example, gene disruption and proto-oncogene activation)—have slowed progress and limited clinical success<i></i><sup><a href="#ref-51">51</a></sup>.</p><p class="" id=d85322e468>Alternately, novel ways of interrupting protein expression based on RNA interference technologies have also been developed in order to disrupt protein function at the level of transcription by binding to mRNA transcripts and marking them for degradation. Despite their enormous utility, RNA interference techniques suffer from the inability to target post-translational modifications, instability, and off-target effects as well as issues associated with viral delivery as discussed above. Conversely, transfection with mRNA transcripts can bypass transcriptional controls and does not require entry into the nucleus, thus permitting direct expression of encoded proteins even in non-dividing cells. Despite these advantages over transfection with DNA and utility for transient expression of proteins, studies have continued to note variation in expressed protein levels<sup><a href="#ref-52">52</a></sup> that will need to be addressed for realization of its therapeutic potential.</p><p class="" id=d85322e475>As a result of these limitations, a variety of means of direct introduction of proteins into cells have been explored. Numerous transfection technologies employed for polynucleotides are facilitated by the relative uniformity of their physicochemical properties and overall negative charge arising from their phosphate-sugar backbone. In contrast, proteins lack uniform charge density and possess a broader chemical make-up that makes a single, widely applicable approach to transduction challenging. Accordingly, a number of <i>in vitro</i> approaches have emerged for the general aim of ‘profection’ or protein transduction into cells, some of which have only just begun to address the possibility of <i>in vivo</i> delivery.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d85322e487>Physical methods of protein delivery</h2><p class="" id=d85322e490>Electroporation is the transient permeabilization of cells with short bursts of high voltage to allow uptake of biomolecules. Though widely used for DNA delivery, it has also been explored for protein transduction in which uptake and observation of activity are rapid in comparison with indirect expression from DNA<sup><a href="#ref-54">54</a>,<a href="#ref-55">55</a></sup>. Electroporation is useful because it avoids endosomal trapping by bypassing the endocytic machinery, but it can be used only on small numbers of cells and may cause excessive cell death or aggregation of the protein to be delivered<sup><a href="#ref-53">53</a></sup>. Similar approaches have been explored by using sound<sup><a href="#ref-54">54</a></sup>, physical deformation caused by passage through a microfluidic device<sup><a href="#ref-55">55</a></sup>, or reversible permeabilization with cholesterol-binding agents<sup><a href="#ref-56">56</a></sup>.</p><p class="" id=d85322e516>Protein-based biosensors or signaling modulators have also been introduced into cells by microinjection, and these highlight the advantages of high transduction efficiencies (even in difficult-to-transduce cells)<sup><a href="#ref-58">58</a>–<a href="#ref-62">62</a></sup>, spatial and temporal control (thus circumventing endosomal trapping issues), and precisely controlled dosing<sup><a href="#ref-57">57</a></sup>. Novel, photo-sensitive nanocarrier protein complexes coupled with light-based activation techniques are similar to microinjection and may offer increased spatial and temporal control over sites and the frequency of protein delivery<sup><a href="#ref-58">58</a></sup>. Nevertheless, all of these techniques are limited to small numbers of cells and are likely difficult to adapt for therapeutic delivery.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d85322e537>Protein delivery with cationic lipids, liposomes, and polymerosomes</h2><p class="" id=d85322e540>Lipid vesicles and polymeric encapsulation of oligonucleotides are widely used methods for the delivery of DNA and RNA into cells. Similar approaches to protein delivery, though useful for protecting proteins from serum degradation or neutralization, can encounter challenges for encapsulation because of the variable stability and greater chemical and structural diversity of proteins. Conventional liposome preparation methods often employ conditions (that is, solvents, sonication, detergents, and so on) that can lead to protein denaturation and loss of activity<sup><a href="#ref-59">59</a></sup>. Alternatively, polycationic lipids, similar to those used for transfection of DNA, have been explored and shown to be effective for intracellular delivery of functionally active proteins <i>in vitro</i> using a variety of formulations<sup><a href="#ref-66">66</a>,<a href="#ref-67">67</a></sup>. Recent studies using lipid complexes of supercharged anionic GFP-Cre protein and Cas9:single guide RNA complex injected into the inner ear of live mice confirm delivery, functional protein activity, and recombinational events in a restricted <i>in vivo</i> milieu<sup><a href="#ref-60">60</a></sup>. Though cationic lipid preparations have been used systemically for the experimental delivery of genes <i>in vivo</i><sup><a href="#ref-61">61</a></sup>, investigations of the distribution and effective protein transduction for systemically administered polycationic lipid:protein complexes have not, to our knowledge, been reported.</p><p class="" id=d85322e571>Additional liposome and polymer-based platforms for protein delivery have been described using labile particles that are stable outside the cell but decompose upon exposure to either low pH<sup><a href="#ref-62">62</a>–<a href="#ref-65">65</a></sup> or reducing environments<sup><a href="#ref-66">66</a></sup> in a manner that facilitates protein release and exit from endosomes. These studies confirm the entry, distribution, and functional ability of intact antibodies to block the biological role of target proteins inside cells<sup><a href="#ref-62">62</a>,<a href="#ref-63">63</a></sup>. Mechanistic insights into ‘polymerosome’ uptake suggest a role for receptor-mediated uptake via class B scavenger receptors (that is, CD36 and SR-BI/II) rather than direct entry, suggesting a particle structure similar to endogenous scavenger receptor ligands (for example, high- and low-density lipoproteins)<sup><a href="#ref-67">67</a></sup> and that alternate formulations of the polymer may enable targeting of other receptors for uptake. Additional studies showed that polymerosomes conjugated with a low-density lipoprotein receptor-related protein-1 (LRP1) ligand and loaded with IgG mediated both transcytosis across the blood-brain barrier and uptake by cells of the central nervous system when injected intravenously into mice<sup><a href="#ref-68">68</a></sup>. Additional studies support the use of receptors that mediate transcytosis for the delivery of antibodies<sup><a href="#ref-69">69</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d85322e609>Protein transduction domains</h2><p class="" id=d85322e612>Numerous studies have been published describing the use of designed CPPs or small protein transduction domains (PTDs) as agents capable of delivering proteins into cells. Although the terms CPP and PTD are often used interchangeably in the literature, we employ the terms in a more strict sense in which peptide-based reagents are referred to as CPPs and autonomously folding domains—for example, CH2-His2 zinc-finger domains—are referred to as PTDs. They are numerous but can be broadly classified as cationic peptides, including human immunodeficiency virus type I (HIV) Tat peptides<sup><a href="#ref-70">70</a></sup>, <i>Drosophila</i> Antennapedia homeoprotein (Antp 43-58)/penetratin<sup><a href="#ref-71">71</a>,<a href="#ref-72">72</a></sup>, poly arginine<sup><a href="#ref-73">73</a></sup>, amphipathic peptides such as transportan<sup><a href="#ref-74">74</a></sup>, MPG<sup><a href="#ref-75">75</a>,<a href="#ref-76">76</a></sup>, MAP<sup><a href="#ref-77">77</a></sup>, and Pep-1<sup><a href="#ref-78">78</a></sup>, and hydrophobic peptides<sup><a href="#ref-79">79</a></sup>. Various CPPs, including TAT<sup><a href="#ref-80">80</a>–<a href="#ref-82">82</a></sup>, rabies virus glycoprotein<sup><a href="#ref-83">83</a></sup>, a fibroblast growth factor four-derived peptide<sup><a href="#ref-84">84</a></sup>, and annexin-derived peptides<sup><a href="#ref-48">48</a></sup>, have been used to investigate the <i>in vivo</i> distribution of CPP-tagged cargo proteins. In addition to revealing widespread tissue distribution with no apparent cell-type dependence<sup><a href="#ref-81">81</a>,<a href="#ref-84">84</a>,<a href="#ref-85">85</a></sup>, studies appear to confirm sufficient delivery across the blood-brain barrier to achieve a neuroprotective effect in models of brain insult<sup><a href="#ref-80">80</a>,<a href="#ref-82">82</a>,<a href="#ref-83">83</a>,<a href="#ref-86">86</a></sup>.</p><p class="" id=d85322e703>However, initial claims of a temperature- and energy-independent (that is, non-endocytic) mechanism<sup><a href="#ref-71">71</a></sup> were met with skepticism and triggered a deeper investigation of the means of translocation that ultimately revealed previously unrecognized issues with cell-surface adhesion<sup><a href="#ref-87">87</a></sup>, artifacts of fixation<sup><a href="#ref-88">88</a></sup>, and endosomal trapping<sup><a href="#ref-89">89</a></sup>. Though further studies have confirmed the role that one or more endocytic pathways play in uptake (including macropinocytosis and clathrin-, caveolin-, and receptor-mediated uptake)<sup><a href="#ref-89">89</a>–<a href="#ref-92">92</a></sup>, in addition to a potential contribution by direct entry<sup><a href="#ref-93">93</a></sup>, it is apparent that cytosolic delivery of protein cargo is not guaranteed in all applications and that the mechanism and degree of endosomal release are ongoing challenges that need to be addressed to realize the therapeutic potential of CPPs<sup><a href="#ref-94">94</a></sup>. The field also suffers from the general lack of an objective comparison of the transduction efficiency, distribution, and cellular fate of more than one CPP. Though studies of this type would be both informative and helpful in dispelling some of the controversy and confusion, the observed dependence of delivery on factors, including the length and specific properties of the CPP, cargo type, CPP-cargo linkers, and cell type<sup><a href="#ref-95">95</a>,<a href="#ref-96">96</a></sup>, complicates a clear and quantitative comparison of transduction efficiencies of various CPPs <i>in vitro</i>, and only a handful of studies even attempt such a description<sup><a href="#ref-79">79</a>,<a href="#ref-97">97</a>–<a href="#ref-99">99</a></sup>.</p><p class="" id=d85322e758>In addition, despite the many successes of both natural and designed CPPs to effectively deliver protein cargo, their ability to broadly transduce cells and tissues <i>in vivo</i> may actually be an impediment to therapeutic<i></i> applications without additional targeting efforts to ensure delivery to desired tissues. Alternately, novel approaches based on natural mechanisms of tissue specificity and cellular entry may offer solutions to delivering bioactive proteins to target tissues in an <i>in vivo</i> setting.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d85322e772>Virus-like particles</h2><p class="" id=d85322e775>Virus-like particles (VLPs) are self-assembling particles composed of viral capsid proteins that, though lacking the genetic components required for infective virus assembly, nevertheless resemble native viruses and enter cells in a similar fashion<sup><a href="#ref-100">100</a>–<a href="#ref-102">102</a></sup>. During self-assembly, their ability to encapsidate a variety of non-viral biomolecules, including DNA<sup><a href="#ref-103">103</a>,<a href="#ref-104">104</a></sup>, RNA<sup><a href="#ref-105">105</a></sup>, small-molecule drugs<sup><a href="#ref-105">105</a></sup>, and proteins<sup><a href="#ref-106">106</a>,<a href="#ref-107">107</a></sup>, has piqued substantial interest in their development as drug and vaccine delivery agents<sup><a href="#ref-108">108</a></sup>. To this end, VLPs can be engineered to express and display heterologous proteins<sup><a href="#ref-109">109</a>,<a href="#ref-110">110</a></sup> and have been exploited primarily as vaccine carriers for their immunogenic and adjuvant properties and ability to carry cargo into the cell interior<sup><a href="#ref-111">111</a>,<a href="#ref-112">112</a></sup>.</p><p class="" id=d85322e826>The advantages of direct over indirect protein transduction are being recognized, and the potential of VLPs to act as protein transduction agents for the delivery of bioactive proteins to cells is being explored. A growing number of VLP systems have been shown to be amenable to the packaging and intracellular delivery of proteins: polyomavirus<sup><a href="#ref-113">113</a></sup>, murine leukemia virus<sup><a href="#ref-114">114</a></sup>, hepatitis B virus<sup><a href="#ref-115">115</a></sup>, lentivirus<sup><a href="#ref-116">116</a>,<a href="#ref-117">117</a></sup>, retrovirus<sup><a href="#ref-118">118</a></sup>, Sendai virus<sup><a href="#ref-119">119</a></sup>, and Sesbania mosaic plant virus<sup><a href="#ref-109">109</a></sup>. Most notably, the delivery of bioactive proteins such as antibodies<sup><a href="#ref-109">109</a>,<a href="#ref-119">119</a></sup>, transcription factors<sup><a href="#ref-114">114</a>,<a href="#ref-118">118</a></sup>, and enzymes<sup><a href="#ref-110">110</a>,<a href="#ref-116">116</a>,<a href="#ref-117">117</a></sup> has been confirmed both <i>in vitro</i><sup><a href="#ref-110">110</a>,<a href="#ref-114">114</a>,<a href="#ref-116">116</a></sup><i></i> and <i>in vivo</i><sup><a href="#ref-117">117</a></sup>.</p><p class="" id=d85322e905>As therapeutic<i></i> administration requires targeting of diseased cells and tissues <i>in vivo</i>, particle distribution is a key consideration in the development of any protein delivery platform. Though some viruses possess natural cell and tissue tropism<sup><a href="#ref-120">120</a></sup>, the broad cell specificity exhibited by many of the viruses currently used for delivery would hamper their development as therapeutic agents. It is the opportunity to re-direct or focus broad tropisms for therapeutic advantage that is particularly appealing. Illustrative studies employing different approaches to incorporating antibody scFvs into VLPs have been described by binding to a capsid fusion of the <i>Staphylococcal aureus</i> A<i></i> protein Z domain<sup><a href="#ref-121">121</a></sup>, incorporation of polyionic fusion peptides with an engineered disulfide bond<sup><a href="#ref-122">122</a></sup>, or tagging with the hemagglutinin transmembrane domain<sup><a href="#ref-123">123</a></sup> or a glycosylphosphatidylinositol (GPI) anchor<sup><a href="#ref-124">124</a></sup>. Although these studies provide evidence of <i>in vitro</i> cell selectivity, a recent study using peptides obtained from selection against surface antigens on human hepatocellular carcinoma cells offers a preliminary example of engineered <i>in vivo</i> cell selectivity<sup><a href="#ref-125">125</a></sup> and suggests that this may be a potentially viable approach for tailoring VLPs for therapeutic targeting (<a href="#f2">Figure 2</a>).</p><div class="fig panel clearfix"><a name=f2 class=n-a></a><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/9593/f71c1e78-bcee-4eed-a790-aae843012f87_figure2.gif"><img alt="f71c1e78-bcee-4eed-a790-aae843012f87_figure2.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/9593/f71c1e78-bcee-4eed-a790-aae843012f87_figure2.gif"></a><div class=caption><h3>Figure 2. Methods for the direct delivery of proteins into cells.</h3><p id=d85322e963>A variety of methods have been described for delivering functional protein to the cell interior and are illustrated along with potential mechanisms of uptake and endosomal release. CPP, cell-penetrating peptide; PTD, protein transduction domain; VLP, virus-like particle.</p></div></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d85322e973>Future perspectives</h2><p class="" id=d85322e976>As the field of protein engineering advances the development of novel protein scaffolds targeting an increasingly broad segment of the proteome, techniques for protein delivery into cells will likely progress apace. The pioneering examples of non-antibody scaffolds with the ability to modulate intracellular proteins, signaling outcomes, and cell biology provide increasing confidence that they possess therapeutic value and provide incentive for developing innovative and reliable techniques for intracellular protein delivery both <i>in vitro</i> and <i>in vivo</i>. Current studies provide proof of principle that these aims are within reach, but few examples provide detailed comparisons of delivery mechanisms or analysis of the distribution and fate of delivered proteins. Despite this, new approaches to delivering proteins to the cell interior continue to be advanced. In addition to novel PTD mimics<sup><a href="#ref-126">126</a></sup>, other platforms, including supercharged proteins<sup><a href="#ref-127">127</a></sup>, bacterial toxins<sup><a href="#ref-128">128</a></sup>, and zinc-finger domains<sup><a href="#ref-129">129</a></sup>, have been described. Chemical modifications have also been extensively explored for targeted delivery of protein- and RNA-based drugs and may also offer valuable solutions for <i>in vivo</i> targeting<sup><a href="#ref-130">130</a>,<a href="#ref-131">131</a></sup>. However, in the absence of comprehensive comparisons of uptake, intracellular distribution, and degradation, it is difficult to assess which approach to intracellular delivery is best. From a pharmacological standpoint, these features (that is, the path, destination(s), and lifetime of a delivered agent) will determine whether a delivered protein drug interacts with its target in its native cellular compartment, for how long it interacts and modifies the activity of the target protein, and how the protein drug is ultimately neutralized or degraded. These are features that undoubtedly underlie the effectiveness of a protein drug whose target is found inside the cell and must be characterized to develop effective formulation and dosing regimens that ensure efficacy and avoid toxicity.</p><p class="" id=d85322e1012>Many of the approaches described thus far have relied on endosomal uptake and may suffer from reduced therapeutic efficacy due to entrapment. Though problematic, efforts toward developing platforms that address this challenge<sup><a href="#ref-62">62</a>–<a href="#ref-65">65</a></sup> as well as toward developing additional means of escape<sup><a href="#ref-34">34</a>,<a href="#ref-132">132</a></sup> may offer viable solutions. Although a preliminary aim of intracellular delivery is to access the cytosol, numerous targets of therapeutic interest are sequestered in other compartments<sup><a href="#ref-133">133</a></sup>. Intracellular targeting efforts using signal sequences to localize delivered proteins to subcellular compartments offer potential means of ensuring co-localization of transduced protein drugs and their targets outside of the cytoplasm<sup><a href="#ref-134">134</a></sup>. Degradation of proteins delivered by using these approaches will also exert substantial influence over protein activity, lifetime, and cost. With the potential to extend the lifetime of virtually any protein-based therapeutic, novel D protein-binding scaffolds constructed from synthetic D amino acids have been introduced and have the potential to obviate concerns about the susceptibility of natural proteins to proteolytic degradation and immunogenicity<sup><a href="#ref-135">135</a>,<a href="#ref-136">136</a></sup>. Furthermore, the small size and high thermostability of many of the non-antibody scaffolds make chemical synthesis and efficient refolding possible, thus reducing cost and avoiding many of the pitfalls associated with production in cellular systems.</p><p class="" id=d85322e1044>These and yet unforeseen approaches and technological innovations will continue to be developed, and it is hoped that they will converge with a primary focus on <i>in vivo</i>-targeted delivery of active therapeutic proteins. Consequently, what is now only a lofty goal of using therapeutic proteins inside cells may soon morph into an attainable approach for the treatment of complex pathologies that resist current therapeutic approaches.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d85322e1 class=n-a></a><h2 class=main-title id=d85703>Competing interests</h2><p class=metadata-entry><a name=d85322e100 class=n-a></a><p id=d85322e101> The authors declare that they have no competing interests.</p></p></div><div class=back-section><a name=d85322e1 class=n-a></a><h2 class=main-title id=d85705>Grant information</h2><p>The author(s) declared that no grants were involved in supporting this work.</p></div><div class=back-section><a name=d85322e1054 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d86162>References</h2><div class="section ref-list"><a name=d85322e1054 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d85322e1061 class=n-a></a>Argos P: An investigation of protein subunit and domain interfaces. <i>Protein Eng.</i> 1988; <b>2</b>(2): 101–13. <a target=xrefwindow id=d85322e1069 href="http://www.ncbi.nlm.nih.gov/pubmed/3244692">PubMed Abstract </a> | <a target=xrefwindow id=d85322e1072 href="http://dx.doi.org/10.1093/protein/2.2.101">Publisher Full Text </a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d85322e1081 class=n-a></a>Jones S, Thornton JM: Analysis of protein-protein interaction sites using surface patches. <i>J Mol Biol.</i> 1997; <b>272</b>(1): 121–32. <a target=xrefwindow id=d85322e1089 href="http://www.ncbi.nlm.nih.gov/pubmed/9299342">PubMed Abstract </a> | <a target=xrefwindow id=d85322e1092 href="http://dx.doi.org/10.1006/jmbi.1997.1234">Publisher Full Text </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d85322e1101 class=n-a></a>Jones S, Thornton JM: Principles of protein-protein interactions. <i>Proc Natl Acad Sci U S A.</i> 1996; <b>93</b>(1): 13–20. <a target=xrefwindow id=d85322e1109 href="http://www.ncbi.nlm.nih.gov/pubmed/8552589">PubMed Abstract </a> | <a target=xrefwindow id=d85322e1112 href="http://dx.doi.org/10.1073/pnas.93.1.13">Publisher Full Text </a> | <a target=xrefwindow id=d85322e1115 href="http://www.ncbi.nlm.nih.gov/pmc/articles/40170">Free Full Text </a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a name=d85322e1124 class=n-a></a>Janin J, Chothia C: The structure of protein-protein recognition sites. <i>J Biol Chem.</i> 1990; <b>265</b>(27): 16027–30. <a target=xrefwindow id=d85322e1132 href="http://www.ncbi.nlm.nih.gov/pubmed/2204619">PubMed Abstract </a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a name=d85322e1141 class=n-a></a>Vajda S, Guarnieri F: Characterization of protein-ligand interaction sites using experimental and computational methods. <i>Curr Opin Drug Discov Devel.</i> 2006; <b>9</b>(3): 354–62. <a target=xrefwindow id=d85322e1149 href="http://www.ncbi.nlm.nih.gov/pubmed/16729732">PubMed Abstract </a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a name=d85322e1159 class=n-a></a>Hopkins AL, Groom CR: The druggable genome. <i>Nat Rev Drug Discov.</i> 2002; <b>1</b>(9): 727–30. <a target=xrefwindow id=d85322e1167 href="http://www.ncbi.nlm.nih.gov/pubmed/12209152">PubMed Abstract </a> | <a target=xrefwindow id=d85322e1170 href="http://dx.doi.org/10.1038/nrd892">Publisher Full Text </a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a name=d85322e1179 class=n-a></a>Arkin MR, Tang Y, Wells JA: Small-molecule inhibitors of protein-protein interactions: progressing toward the reality. <i>Chem Biol.</i> 2014; <b>21</b>(9): 1102–14. <a target=xrefwindow id=d85322e1187 href="http://www.ncbi.nlm.nih.gov/pubmed/25237857">PubMed Abstract </a> | <a target=xrefwindow id=d85322e1190 href="http://dx.doi.org/10.1016/j.chembiol.2014.09.001">Publisher Full Text </a> | <a target=xrefwindow id=d85322e1193 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4179228">Free Full Text </a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d85322e1202 class=n-a></a>De Genst E, Silence K, Decanniere K, <i> et al.</i>: Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies. <i>Proc Natl Acad Sci U S A.</i> 2006; <b>103</b>(12): 4586–91. <a target=xrefwindow id=d85322e1213 href="http://www.ncbi.nlm.nih.gov/pubmed/16537393">PubMed Abstract </a> | <a target=xrefwindow id=d85322e1216 href="http://dx.doi.org/10.1073/pnas.0505379103">Publisher Full Text </a> | <a target=xrefwindow id=d85322e1220 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1450215">Free Full Text </a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d85322e1229 class=n-a></a>Rouet R, Dudgeon K, Christie M, <i> et al.</i>: Fully Human V<sub>H</sub> Single Domains That Rival the Stability and Cleft Recognition of Camelid Antibodies. <i>J Biol Chem.</i> 2015; <b>290</b>(19): 11905–17. <a target=xrefwindow id=d85322e1243 href="http://www.ncbi.nlm.nih.gov/pubmed/25737448">PubMed Abstract </a> | <a target=xrefwindow id=d85322e1247 href="http://dx.doi.org/10.1074/jbc.M114.614842">Publisher Full Text </a> | <a target=xrefwindow id=d85322e1250 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4424330">Free Full Text </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/725287422"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d85322e1259 class=n-a></a>Ecker DM, Jones SD, Levine HL: The therapeutic monoclonal antibody market. <i>MAbs.</i> 2015; <b>7</b>(1): 9–14. <a target=xrefwindow id=d85322e1267 href="http://www.ncbi.nlm.nih.gov/pubmed/25529996">PubMed Abstract </a> | <a target=xrefwindow id=d85322e1270 href="http://dx.doi.org/10.4161/19420862.2015.989042">Publisher Full Text </a> | <a target=xrefwindow id=d85322e1273 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4622599">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/725287422">F1000 Recommendation</a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a name=d85322e1286 class=n-a></a>Tomlinson IM: Next-generation protein drugs. <i>Nat Biotechnol.</i> 2004; <b>22</b>(5): 521–2. <a target=xrefwindow id=d85322e1294 href="http://www.ncbi.nlm.nih.gov/pubmed/15122287">PubMed Abstract </a> | <a target=xrefwindow id=d85322e1297 href="http://dx.doi.org/10.1038/nbt0504-521">Publisher Full Text </a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/725786125"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d85322e1307 class=n-a></a>Vazquez-Lombardi R, Phan TG, Zimmermann C, <i> et al.</i>: Challenges and opportunities for non-antibody scaffold drugs. <i>Drug Discov Today.</i> 2015; <b>20</b>(10): 1271–83. <a target=xrefwindow id=d85322e1318 href="http://www.ncbi.nlm.nih.gov/pubmed/26360055">PubMed Abstract </a> | <a target=xrefwindow id=d85322e1321 href="http://dx.doi.org/10.1016/j.drudis.2015.09.004">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/725786125">F1000 Recommendation</a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a name=d85322e1334 class=n-a></a>Cardinale A, Biocca S: The potential of intracellular antibodies for therapeutic targeting of protein-misfolding diseases. <i>Trends Mol Med.</i> 2008; <b>14</b>(9): 373–80. <a target=xrefwindow id=d85322e1342 href="http://www.ncbi.nlm.nih.gov/pubmed/18693139">PubMed Abstract </a> | <a target=xrefwindow id=d85322e1345 href="http://dx.doi.org/10.1016/j.molmed.2008.07.004">Publisher Full Text </a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/718164448"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d85322e1354 class=n-a></a>Hong CW, Zeng Q: Tapping the treasure of intracellular oncotargets with immunotherapy. <i>FEBS Lett.</i> 2014; <b>588</b>(2): 350–5. <a target=xrefwindow id=d85322e1362 href="http://www.ncbi.nlm.nih.gov/pubmed/24184114">PubMed Abstract </a> | <a target=xrefwindow id=d85322e1365 href="http://dx.doi.org/10.1016/j.febslet.2013.10.025">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/718164448">F1000 Recommendation</a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a name=d85322e1378 class=n-a></a>Rubinsztein DC, Codogno P, Levine B: Autophagy modulation as a potential therapeutic target for diverse diseases. <i>Nat Rev Drug Discov.</i> 2012; <b>11</b>(9): 709–30. <a target=xrefwindow id=d85322e1386 href="http://www.ncbi.nlm.nih.gov/pubmed/22935804">PubMed Abstract </a> | <a target=xrefwindow id=d85322e1389 href="http://dx.doi.org/10.1038/nrd3802">Publisher Full Text </a> | <a target=xrefwindow id=d85322e1392 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3518431">Free Full Text </a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a name=d85322e1401 class=n-a></a>Biocca S, Neuberger MS, Cattaneo A: Expression and targeting of intracellular antibodies in mammalian cells. <i>EMBO J.</i> 1990; <b>9</b>(1): 101–8. <a target=xrefwindow id=d85322e1409 href="http://www.ncbi.nlm.nih.gov/pubmed/2153072">PubMed Abstract </a> | <a target=xrefwindow id=d85322e1412 href="http://www.ncbi.nlm.nih.gov/pmc/articles/551635">Free Full Text </a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a name=d85322e1421 class=n-a></a>Lin JJ, Feramisco JR: Disruption of the <i>in vivo</i> distribution of the intermediate filaments in fibroblasts through the microinjection of a specific monoclonal antibody. <i>Cell.</i> 1981; <b>24</b>(1): 185–93. <a target=xrefwindow id=d85322e1432 href="http://www.ncbi.nlm.nih.gov/pubmed/7016335">PubMed Abstract </a> | <a target=xrefwindow id=d85322e1435 href="http://dx.doi.org/10.1016/0092-8674(81)90514-6">Publisher Full Text </a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a name=d85322e1445 class=n-a></a>Yuan Q, Strauch KL, Lobb RR, <i> et al.</i>: Intracellular single-chain antibody inhibits integrin VLA-4 maturation and function. <i>Biochem J.</i> 1996; <b>318</b>(Pt 2): 591–6. <a target=xrefwindow id=d85322e1456 href="http://www.ncbi.nlm.nih.gov/pubmed/8809051">PubMed Abstract </a> | <a target=xrefwindow id=d85322e1459 href="http://dx.doi.org/10.1042/bj3180591">Publisher Full Text </a> | <a target=xrefwindow id=d85322e1463 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1217661">Free Full Text </a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a name=d85322e1472 class=n-a></a>Levin R, Mhashilkar AM, Dorfman T, <i> et al.</i>: Inhibition of early and late events of the HIV-1 replication cycle by cytoplasmic Fab intrabodies against the matrix protein, p17. <i>Mol Med.</i> 1997; <b>3</b>(2): 96–110. <a target=xrefwindow id=d85322e1483 href="http://www.ncbi.nlm.nih.gov/pubmed/9085253">PubMed Abstract </a> | <a target=xrefwindow id=d85322e1486 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2230055">Free Full Text </a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a name=d85322e1495 class=n-a></a>Steinberger P, Andris-Widhopf J, Bühler B, <i> et al.</i>: Functional deletion of the CCR5 receptor by intracellular immunization produces cells that are refractory to CCR5-dependent HIV-1 infection and cell fusion. <i>Proc Natl Acad Sci U S A.</i> 2000; <b>97</b>(2): 805–10. <a target=xrefwindow id=d85322e1506 href="http://www.ncbi.nlm.nih.gov/pubmed/10639161">PubMed Abstract </a> | <a target=xrefwindow id=d85322e1509 href="http://dx.doi.org/10.1073/pnas.97.2.805">Publisher Full Text </a> | <a target=xrefwindow id=d85322e1513 href="http://www.ncbi.nlm.nih.gov/pmc/articles/15412">Free Full Text </a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a name=d85322e1522 class=n-a></a>Marasco WA, Haseltine WA, Chen SY: Design, intracellular expression, and activity of a human anti-human immunodeficiency virus type 1 gp120 single-chain antibody. <i>Proc Natl Acad Sci U S A.</i> 1993; <b>90</b>(16): 7889–93. <a target=xrefwindow id=d85322e1530 href="http://www.ncbi.nlm.nih.gov/pubmed/8356098">PubMed Abstract </a> | <a target=xrefwindow id=d85322e1533 href="http://dx.doi.org/10.1073/pnas.90.16.7889">Publisher Full Text </a> | <a target=xrefwindow id=d85322e1536 href="http://www.ncbi.nlm.nih.gov/pmc/articles/47248">Free Full Text </a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a name=d85322e1545 class=n-a></a>Jung S, Plückthun A: Improving <i>in vivo</i> folding and stability of a single-chain Fv antibody fragment by loop grafting. <i>Protein Eng.</i> 1997; <b>10</b>(8): 959–66. <a target=xrefwindow id=d85322e1556 href="http://www.ncbi.nlm.nih.gov/pubmed/9415446">PubMed Abstract </a> | <a target=xrefwindow id=d85322e1559 href="http://dx.doi.org/10.1093/protein/10.8.959">Publisher Full Text </a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a name=d85322e1568 class=n-a></a>Wörn A, Plückthun A: Stability engineering of antibody single-chain Fv fragments. <i>J Mol Biol.</i> 2001; <b>305</b>(5): 989–1010. <a target=xrefwindow id=d85322e1576 href="http://www.ncbi.nlm.nih.gov/pubmed/11162109">PubMed Abstract </a> | <a target=xrefwindow id=d85322e1579 href="http://dx.doi.org/10.1006/jmbi.2000.4265">Publisher Full Text </a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a name=d85322e1589 class=n-a></a>Barthelemy PA, Raab H, Appleton BA, <i> et al.</i>: Comprehensive analysis of the factors contributing to the stability and solubility of autonomous human V<sub>H</sub> domains. <i>J Biol Chem.</i> 2008; <b>283</b>(6): 3639–54. <a target=xrefwindow id=d85322e1603 href="http://www.ncbi.nlm.nih.gov/pubmed/18045863">PubMed Abstract </a> | <a target=xrefwindow id=d85322e1607 href="http://dx.doi.org/10.1074/jbc.M708536200">Publisher Full Text </a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a name=d85322e1616 class=n-a></a>Tanaka T, Rabbitts TH: Intrabodies based on intracellular capture frameworks that bind the RAS protein with high affinity and impair oncogenic transformation. <i>EMBO J.</i> 2003; <b>22</b>(5): 1025–35. <a target=xrefwindow id=d85322e1624 href="http://www.ncbi.nlm.nih.gov/pubmed/12606568">PubMed Abstract </a> | <a target=xrefwindow id=d85322e1627 href="http://dx.doi.org/10.1093/emboj/cdg106">Publisher Full Text </a> | <a target=xrefwindow id=d85322e1630 href="http://www.ncbi.nlm.nih.gov/pmc/articles/150339">Free Full Text </a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a name=d85322e1639 class=n-a></a>Dudgeon K, Rouet R, Kokmeijer I, <i> et al.</i>: General strategy for the generation of human antibody variable domains with increased aggregation resistance. <i>Proc Natl Acad Sci U S A.</i> 2012; <b>109</b>(27): 10879–84. <a target=xrefwindow id=d85322e1650 href="http://www.ncbi.nlm.nih.gov/pubmed/22745168">PubMed Abstract </a> | <a target=xrefwindow id=d85322e1653 href="http://dx.doi.org/10.1073/pnas.1202866109">Publisher Full Text </a> | <a target=xrefwindow id=d85322e1657 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3390889">Free Full Text </a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a name=d85322e1666 class=n-a></a>Ewert S, Honegger A, Plückthun A: Structure-based improvement of the biophysical properties of immunoglobulin V<sub>H</sub> domains with a generalizable approach. <i>Biochemistry.</i> 2003; <b>42</b>(6): 1517–28. <a target=xrefwindow id=d85322e1677 href="http://www.ncbi.nlm.nih.gov/pubmed/12578364">PubMed Abstract </a> | <a target=xrefwindow id=d85322e1680 href="http://dx.doi.org/10.1021/bi026448p">Publisher Full Text </a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a name=d85322e1689 class=n-a></a>der Maur AA, Zahnd C, Fischer F, <i> et al.</i>: Direct <i>in vivo</i> screening of intrabody libraries constructed on a highly stable single-chain framework. <i>J Biol Chem.</i> 2002; <b>277</b>(47): 45075–85. <a target=xrefwindow id=d85322e1703 href="http://www.ncbi.nlm.nih.gov/pubmed/12215438">PubMed Abstract </a> | <a target=xrefwindow id=d85322e1707 href="http://dx.doi.org/10.1074/jbc.M205264200">Publisher Full Text </a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a name=d85322e1716 class=n-a></a>Tse E, Lobato MN, Forster A, <i> et al.</i>: Intracellular antibody capture technology: application to selection of intracellular antibodies recognising the BCR-ABL oncogenic protein. <i>J Mol Biol.</i> 2002; <b>317</b>(1): 85–94. <a target=xrefwindow id=d85322e1727 href="http://www.ncbi.nlm.nih.gov/pubmed/11916380">PubMed Abstract </a> | <a target=xrefwindow id=d85322e1730 href="http://dx.doi.org/10.1006/jmbi.2002.5403">Publisher Full Text </a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a name=d85322e1740 class=n-a></a>Visintin M, Tse E, Axelson H, <i> et al.</i>: Selection of antibodies for intracellular function using a two-hybrid <i>in vivo</i> system. <i>Proc Natl Acad Sci U S A.</i> 1999; <b>96</b>(21): 11723–8. <a target=xrefwindow id=d85322e1754 href="http://www.ncbi.nlm.nih.gov/pubmed/10518517">PubMed Abstract </a> | <a target=xrefwindow id=d85322e1758 href="http://dx.doi.org/10.1073/pnas.96.21.11723">Publisher Full Text </a> | <a target=xrefwindow id=d85322e1761 href="http://www.ncbi.nlm.nih.gov/pmc/articles/18353">Free Full Text </a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a name=d85322e1770 class=n-a></a>Wheeler YY, Chen SY, Sane DC: <i>Intrabody and intrakine strategies for molecular therapy</i>. <i>Mol Ther.</i> 2003; <b>8</b>(3): 355–66. <a target=xrefwindow id=d85322e1781 href="http://www.ncbi.nlm.nih.gov/pubmed/12946308">PubMed Abstract </a> | <a target=xrefwindow id=d85322e1784 href="http://dx.doi.org/10.1016/S1525-0016(03)00183-7">Publisher Full Text </a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a name=d85322e1793 class=n-a></a>Lo AS, Zhu Q, Marasco WA: Intracellular antibodies (intrabodies) and their therapeutic potential. <i>Handb Exp Pharmacol.</i> 2008; (181): 343–73. <a target=xrefwindow id=d85322e1798 href="http://www.ncbi.nlm.nih.gov/pubmed/18071953">PubMed Abstract </a> | <a target=xrefwindow id=d85322e1801 href="http://dx.doi.org/10.1007/978-3-540-73259-4_15">Publisher Full Text </a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/725705028"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d85322e1810 class=n-a></a>Marschall AL, Dübel S, Böldicke T: Specific <i>in vivo</i> knockdown of protein function by intrabodies. <i>MAbs.</i> 2015; <b>7</b>(6): 1010–35. <a target=xrefwindow id=d85322e1821 href="http://www.ncbi.nlm.nih.gov/pubmed/26252565">PubMed Abstract </a> | <a target=xrefwindow id=d85322e1824 href="http://dx.doi.org/10.1080/19420862.2015.1076601">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/725705028">F1000 Recommendation</a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a name=d85322e1837 class=n-a></a>Li S, Shi L, Yang Z, <i> et al.</i>: Critical roles of <i>Clostridium difficile</i> toxin B enzymatic activities in pathogenesis. <i>Infect Immun.</i> 2015; <b>83</b>(2): 502–13. <a target=xrefwindow id=d85322e1851 href="http://www.ncbi.nlm.nih.gov/pubmed/25404023">PubMed Abstract </a> | <a target=xrefwindow id=d85322e1855 href="http://dx.doi.org/10.1128/IAI.02316-14">Publisher Full Text </a> | <a target=xrefwindow id=d85322e1858 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4294253">Free Full Text </a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a name=d85322e1867 class=n-a></a>Boons E, Li G, Vanstreels E, <i> et al.</i>: A stably expressed llama single-domain intrabody targeting Rev displays broad-spectrum anti-HIV activity. <i>Antiviral Res.</i> 2014; <b>112</b>: 91–102. <a target=xrefwindow id=d85322e1878 href="http://www.ncbi.nlm.nih.gov/pubmed/25453342">PubMed Abstract </a> | <a target=xrefwindow id=d85322e1881 href="http://dx.doi.org/10.1016/j.antiviral.2014.10.007">Publisher Full Text </a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a name=d85322e1891 class=n-a></a>Ordóñez A, Pérez J, Tan L, <i> et al.</i>: A single-chain variable fragment intrabody prevents intracellular polymerization of Z <i>α</i><sub>1</sub>-antitrypsin while allowing its antiproteinase activity. <i>FASEB J.</i> 2015; <b>29</b>(6): 2667–78. <a target=xrefwindow id=d85322e1907 href="http://www.ncbi.nlm.nih.gov/pubmed/25757566">PubMed Abstract </a> | <a target=xrefwindow id=d85322e1911 href="http://dx.doi.org/10.1096/fj.14-267351">Publisher Full Text </a> | <a target=xrefwindow id=d85322e1914 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4548814">Free Full Text </a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a name=d85322e1923 class=n-a></a>Schiefner A, Chatwell L, Körner J, <i> et al.</i>: A disulfide-free single-domain V<sub>L</sub> intrabody with blocking activity towards huntingtin reveals a novel mode of epitope recognition. <i>J Mol Biol.</i> 2011; <b>414</b>(3): 337–55. <a target=xrefwindow id=d85322e1937 href="http://www.ncbi.nlm.nih.gov/pubmed/21968397">PubMed Abstract </a> | <a target=xrefwindow id=d85322e1941 href="http://dx.doi.org/10.1016/j.jmb.2011.09.034">Publisher Full Text </a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/725458225"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d85322e1950 class=n-a></a>Škrlec K, Štrukelj B, Berlec A: Non-immunoglobulin scaffolds: a focus on their targets. <i>Trends Biotechnol.</i> 2015; <b>33</b>(7): 408–18. <a target=xrefwindow id=d85322e1958 href="http://www.ncbi.nlm.nih.gov/pubmed/25931178">PubMed Abstract </a> | <a target=xrefwindow id=d85322e1961 href="http://dx.doi.org/10.1016/j.tibtech.2015.03.012">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/725458225">F1000 Recommendation</a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/717975938"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d85322e1974 class=n-a></a>Ernst A, Avvakumov G, Tong J, <i> et al.</i>: A strategy for modulation of enzymes in the ubiquitin system. <i>Science.</i> 2013; <b>339</b>(6119): 590–5. <a target=xrefwindow id=d85322e1985 href="http://www.ncbi.nlm.nih.gov/pubmed/23287719">PubMed Abstract </a> | <a target=xrefwindow id=d85322e1988 href="http://dx.doi.org/10.1126/science.1230161">Publisher Full Text </a> | <a target=xrefwindow id=d85322e1992 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3815447">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/717975938">F1000 Recommendation</a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a name=d85322e2005 class=n-a></a>Gorelik M, Orlicky S, Sartori MA, <i> et al.</i>: Inhibition of SCF ubiquitin ligases by engineered ubiquitin variants that target the Cul1 binding site on the Skp1-F-box interface. <i>Proc Natl Acad Sci U S A.</i> 2016; <b>113</b>(13): 3527–32. <a target=xrefwindow id=d85322e2016 href="http://www.ncbi.nlm.nih.gov/pubmed/26976582">PubMed Abstract </a> | <a target=xrefwindow id=d85322e2019 href="http://dx.doi.org/10.1073/pnas.1519389113">Publisher Full Text </a> | <a target=xrefwindow id=d85322e2023 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4822621">Free Full Text </a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a name=d85322e2032 class=n-a></a>Zhang W, Wu KP, Sartori MA, <i> et al.</i>: System-Wide Modulation of HECT E3 Ligases with Selective Ubiquitin Variant Probes. <i>Mol Cell.</i> 2016; <b>62</b>(1): 121–36. <a target=xrefwindow id=d85322e2043 href="http://www.ncbi.nlm.nih.gov/pubmed/26949039">PubMed Abstract </a> | <a target=xrefwindow id=d85322e2046 href="http://dx.doi.org/10.1016/j.molcel.2016.02.005">Publisher Full Text </a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a name=d85322e2056 class=n-a></a>Lipovsek D: Adnectins: engineered target-binding protein therapeutics. <i>Protein Eng Des Sel.</i> 2011; <b>24</b>(1–2): 3–9. <a target=xrefwindow id=d85322e2064 href="http://www.ncbi.nlm.nih.gov/pubmed/21068165">PubMed Abstract </a> | <a target=xrefwindow id=d85322e2067 href="http://dx.doi.org/10.1093/protein/gzq097">Publisher Full Text </a> | <a target=xrefwindow id=d85322e2070 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3003446">Free Full Text </a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a name=d85322e2079 class=n-a></a>Tolcher AW, Sweeney CJ, Papadopoulos K, <i> et al.</i>: Phase I and pharmacokinetic study of CT-322 (BMS-844203), a targeted Adnectin inhibitor of VEGFR-2 based on a domain of human fibronectin. <i>Clin Cancer Res.</i> 2011; <b>17</b>(2): 363–71. <a target=xrefwindow id=d85322e2090 href="http://www.ncbi.nlm.nih.gov/pubmed/21224368">PubMed Abstract </a> | <a target=xrefwindow id=d85322e2093 href="http://dx.doi.org/10.1158/1078-0432.CCR-10-1411">Publisher Full Text </a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a name=d85322e2102 class=n-a></a>Gulyani A, Vitriol E, Allen R, <i> et al.</i>: A biosensor generated via high-throughput screening quantifies cell edge Src dynamics. <i>Nat Chem Biol.</i> 2011; <b>7</b>(7): 437–44. <a target=xrefwindow id=d85322e2113 href="http://www.ncbi.nlm.nih.gov/pubmed/21666688">PubMed Abstract </a> | <a target=xrefwindow id=d85322e2116 href="http://dx.doi.org/10.1038/nchembio.585">Publisher Full Text </a> | <a target=xrefwindow id=d85322e2120 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3135387">Free Full Text </a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a name=d85322e2129 class=n-a></a>Kummer L, Hsu CW, Dagliyan O, <i> et al.</i>: Knowledge-based design of a biosensor to quantify localized ERK activation in living cells. <i>Chem Biol.</i> 2013; <b>20</b>(6): 847–56. <a target=xrefwindow id=d85322e2140 href="http://www.ncbi.nlm.nih.gov/pubmed/23790495">PubMed Abstract </a> | <a target=xrefwindow id=d85322e2143 href="http://dx.doi.org/10.1016/j.chembiol.2013.04.016">Publisher Full Text </a> | <a target=xrefwindow id=d85322e2147 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4154710">Free Full Text </a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a name=d85322e2156 class=n-a></a>Grimm S, Lundberg E, Yu F, <i> et al.</i>: Selection and characterisation of affibody molecules inhibiting the interaction between Ras and Raf <i>in vitro</i>. <i>N Biotechnol.</i> 2010; <b>27</b>(6): 766–73. <a target=xrefwindow id=d85322e2170 href="http://www.ncbi.nlm.nih.gov/pubmed/20674812">PubMed Abstract </a> | <a target=xrefwindow id=d85322e2174 href="http://dx.doi.org/10.1016/j.nbt.2010.07.016">Publisher Full Text </a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/726562142"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d85322e2183 class=n-a></a>Shibasaki S, Karasaki M, Gräslund T, <i> et al.</i>: Inhibitory effects of H-Ras/Raf-1-binding affibody molecules on synovial cell function. <i>AMB Express.</i> 2014; <b>4</b>(1): 82. <a target=xrefwindow id=d85322e2194 href="http://www.ncbi.nlm.nih.gov/pubmed/26267111">PubMed Abstract </a> | <a target=xrefwindow id=d85322e2197 href="http://dx.doi.org/10.1186/s13568-014-0082-3">Publisher Full Text </a> | <a target=xrefwindow id=d85322e2201 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4884024">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/726562142">F1000 Recommendation</a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a name=d85322e2215 class=n-a></a>Kim TK, Eberwine JH: Mammalian cell transfection: the present and the future. <i>Anal Bioanal Chem.</i> 2010; <b>397</b>(8): 3173–8. <a target=xrefwindow id=d85322e2223 href="http://www.ncbi.nlm.nih.gov/pubmed/20549496">PubMed Abstract </a> | <a target=xrefwindow id=d85322e2226 href="http://dx.doi.org/10.1007/s00216-010-3821-6">Publisher Full Text </a> | <a target=xrefwindow id=d85322e2229 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2911531">Free Full Text </a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a name=d85322e2238 class=n-a></a>Lv H, Zhang S, Wang B, <i> et al.</i>: Toxicity of cationic lipids and cationic polymers in gene delivery. <i>J Control Release.</i> 2006; <b>114</b>(1): 100–9. <a target=xrefwindow id=d85322e2249 href="http://www.ncbi.nlm.nih.gov/pubmed/16831482">PubMed Abstract </a> | <a target=xrefwindow id=d85322e2252 href="http://dx.doi.org/10.1016/j.jconrel.2006.04.014">Publisher Full Text </a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a name=d85322e2261 class=n-a></a>Giacca M, Zacchigna S: Virus-mediated gene delivery for human gene therapy. <i>J Control Release.</i> 2012; <b>161</b>(2): 377–88. <a target=xrefwindow id=d85322e2269 href="http://www.ncbi.nlm.nih.gov/pubmed/22516095">PubMed Abstract </a> | <a target=xrefwindow id=d85322e2272 href="http://dx.doi.org/10.1016/j.jconrel.2012.04.008">Publisher Full Text </a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a name=d85322e2281 class=n-a></a>Ginn SL, Alexander IE, Edelstein ML, <i> et al.</i>: Gene therapy clinical trials worldwide to 2012 - an update. <i>J Gene Med.</i> 2013; <b>15</b>(2): 65–77. <a target=xrefwindow id=d85322e2292 href="http://www.ncbi.nlm.nih.gov/pubmed/23355455">PubMed Abstract </a> | <a target=xrefwindow id=d85322e2295 href="http://dx.doi.org/10.1002/jgm.2698">Publisher Full Text </a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a name=d85322e2304 class=n-a></a>Leonhardt C, Schwake G, Stögbauer TR, <i> et al.</i>: Single-cell mRNA transfection studies: delivery, kinetics and statistics by numbers. <i>Nanomedicine.</i> 2014; <b>10</b>(4): 679–88. <a target=xrefwindow id=d85322e2315 href="http://www.ncbi.nlm.nih.gov/pubmed/24333584">PubMed Abstract </a> | <a target=xrefwindow id=d85322e2318 href="http://dx.doi.org/10.1016/j.nano.2013.11.008">Publisher Full Text </a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a name=d85322e2327 class=n-a></a>Togtema M, Pichardo S, Jackson R, <i> et al.</i>: Sonoporation delivery of monoclonal antibodies against human papillomavirus 16 E6 restores p53 expression in transformed cervical keratinocytes. <i>PLoS One.</i> 2012; <b>7</b>(11): e50730. <a target=xrefwindow id=d85322e2338 href="http://www.ncbi.nlm.nih.gov/pubmed/23226365">PubMed Abstract </a> | <a target=xrefwindow id=d85322e2341 href="http://dx.doi.org/10.1371/journal.pone.0050730">Publisher Full Text </a> | <a target=xrefwindow id=d85322e2345 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3511358">Free Full Text </a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a name=d85322e2355 class=n-a></a>Sharei A, Zoldan J, Adamo A, <i> et al.</i>: A vector-free microfluidic platform for intracellular delivery. <i>Proc Natl Acad Sci U S A.</i> 2013; <b>110</b>(6): 2082–7. <a target=xrefwindow id=d85322e2366 href="http://www.ncbi.nlm.nih.gov/pubmed/23341631">PubMed Abstract </a> | <a target=xrefwindow id=d85322e2369 href="http://dx.doi.org/10.1073/pnas.1218705110">Publisher Full Text </a> | <a target=xrefwindow id=d85322e2373 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3568376">Free Full Text </a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a name=d85322e2382 class=n-a></a>Michalet X, Pinaud FF, Bentolila LA, <i> et al.</i>: Quantum dots for live cells, <i>in vivo</i> imaging, and diagnostics. <i>Science.</i> 2005; <b>307</b>(5709): 538–44. <a target=xrefwindow id=d85322e2396 href="http://www.ncbi.nlm.nih.gov/pubmed/15681376">PubMed Abstract </a> | <a target=xrefwindow id=d85322e2400 href="http://dx.doi.org/10.1126/science.1104274">Publisher Full Text </a> | <a target=xrefwindow id=d85322e2403 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1201471">Free Full Text </a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a name=d85322e2412 class=n-a></a>Walev I, Bhakdi SC, Hofmann F, <i> et al.</i>: Delivery of proteins into living cells by reversible membrane permeabilization with streptolysin-O. <i>Proc Natl Acad Sci U S A.</i> 2001; <b>98</b>(6): 3185–90. <a target=xrefwindow id=d85322e2423 href="http://www.ncbi.nlm.nih.gov/pubmed/11248053">PubMed Abstract </a> | <a target=xrefwindow id=d85322e2426 href="http://dx.doi.org/10.1073/pnas.051429498">Publisher Full Text </a> | <a target=xrefwindow id=d85322e2430 href="http://www.ncbi.nlm.nih.gov/pmc/articles/30628">Free Full Text </a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/725058049"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d85322e2439 class=n-a></a>Zuris JA, Thompson DB, Shu Y, <i> et al.</i>: Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing <i>in vitro</i> and <i>in vivo</i>. <i>Nat Biotechnol.</i> 2015; <b>33</b>(1): 73–80. <a target=xrefwindow id=d85322e2457 href="http://www.ncbi.nlm.nih.gov/pubmed/25357182">PubMed Abstract </a> | <a target=xrefwindow id=d85322e2460 href="http://dx.doi.org/10.1038/nbt.3081">Publisher Full Text </a> | <a target=xrefwindow id=d85322e2463 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4289409">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/725058049">F1000 Recommendation</a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a name=d85322e2476 class=n-a></a>Liu L, Zern MA, Lizarzaburu ME, <i> et al.</i>: Poly(cationic lipid)-mediated <i>in vivo</i> gene delivery to mouse liver. <i>Gene Ther.</i> 2003; <b>10</b>(2): 180–7. <a target=xrefwindow id=d85322e2490 href="http://www.ncbi.nlm.nih.gov/pubmed/12571647">PubMed Abstract </a> | <a target=xrefwindow id=d85322e2494 href="http://dx.doi.org/10.1038/sj.gt.3301861">Publisher Full Text </a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/726562144"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d85322e2503 class=n-a></a>Postupalenko V, Sibler AP, Desplancq D, <i> et al.</i>: Intracellular delivery of functionally active proteins using self-assembling pyridylthiourea-polyethylenimine. <i>J Control Release.</i> 2014; <b>178</b>: 86–94. <a target=xrefwindow id=d85322e2514 href="http://www.ncbi.nlm.nih.gov/pubmed/24476809">PubMed Abstract </a> | <a target=xrefwindow id=d85322e2517 href="http://dx.doi.org/10.1016/j.jconrel.2014.01.017">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/726562144">F1000 Recommendation</a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a name=d85322e2531 class=n-a></a>Canton I, Massignani M, Patikarnmonthon N, <i> et al.</i>: Fully synthetic polymer vesicles for intracellular delivery of antibodies in live cells. <i>FASEB J.</i> 2013; <b>27</b>(1): 98–108. <a target=xrefwindow id=d85322e2542 href="http://www.ncbi.nlm.nih.gov/pubmed/23033321">PubMed Abstract </a> | <a target=xrefwindow id=d85322e2545 href="http://dx.doi.org/10.1096/fj.12-212183">Publisher Full Text </a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a name=d85322e2554 class=n-a></a>Lackey CA, Press OW, Hoffman AS, <i> et al.</i>: A biomimetic pH-responsive polymer directs endosomal release and intracellular delivery of an endocytosed antibody complex. <i>Bioconjug Chem.</i> 2002; <b>13</b>(5): 996–1001. <a target=xrefwindow id=d85322e2565 href="http://www.ncbi.nlm.nih.gov/pubmed/12236781">PubMed Abstract </a> | <a target=xrefwindow id=d85322e2568 href="http://dx.doi.org/10.1021/bc010053l">Publisher Full Text </a></span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a name=d85322e2577 class=n-a></a>Zhang Y, Yu LC: Single-cell microinjection technology in cell biology. <i>Bioessays.</i> 2008; <b>30</b>(6): 606–10. <a target=xrefwindow id=d85322e2585 href="http://www.ncbi.nlm.nih.gov/pubmed/18478541">PubMed Abstract </a> | <a target=xrefwindow id=d85322e2588 href="http://dx.doi.org/10.1002/bies.20759">Publisher Full Text </a></span></li><li><a name=ref-63 class=n-a></a><span class=label>63. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/725271247"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d85322e2597 class=n-a></a>Morales DP, Braun GB, Pallaoro A, <i> et al.</i>: Targeted intracellular delivery of proteins with spatial and temporal control. <i>Mol Pharm.</i> 2015; <b>12</b>(2): 600–9. <a target=xrefwindow id=d85322e2608 href="http://www.ncbi.nlm.nih.gov/pubmed/25490248">PubMed Abstract </a> | <a target=xrefwindow id=d85322e2611 href="http://dx.doi.org/10.1021/mp500675p">Publisher Full Text </a> | <a target=xrefwindow id=d85322e2615 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4319691">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/725271247">F1000 Recommendation</a></span></li><li><a name=ref-64 class=n-a></a><span class=label>64. </span>&nbsp;<span class=citation><a name=d85322e2628 class=n-a></a>Colletier JP, Chaize B, Winterhalter M, <i> et al.</i>: Protein encapsulation in liposomes: efficiency depends on interactions between protein and phospholipid bilayer. <i>BMC Biotechnol.</i> 2002; <b>2</b>: 9. <a target=xrefwindow id=d85322e2639 href="http://www.ncbi.nlm.nih.gov/pubmed/12003642">PubMed Abstract </a> | <a target=xrefwindow id=d85322e2642 href="http://dx.doi.org/10.1186/1472-6750-2-9">Publisher Full Text </a> | <a target=xrefwindow id=d85322e2646 href="http://www.ncbi.nlm.nih.gov/pmc/articles/113741">Free Full Text </a></span></li><li><a name=ref-65 class=n-a></a><span class=label>65. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/718280440"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d85322e2655 class=n-a></a>Colley HE, Hearnden V, Avila-Olias M, <i> et al.</i>: Polymersome-mediated delivery of combination anticancer therapy to head and neck cancer cells: 2D and 3D <i>in vitro</i> evaluation. <i>Mol Pharm.</i> 2014; <b>11</b>(4): 1176–88. <a target=xrefwindow id=d85322e2669 href="http://www.ncbi.nlm.nih.gov/pubmed/24533501">PubMed Abstract </a> | <a target=xrefwindow id=d85322e2673 href="http://dx.doi.org/10.1021/mp400610b">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/718280440">F1000 Recommendation</a></span></li><li><a name=ref-66 class=n-a></a><span class=label>66. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/725658681"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d85322e2687 class=n-a></a>Tian X, Nyberg S, S Sharp P, <i> et al.</i>: LRP-1-mediated intracellular antibody delivery to the Central Nervous System. <i>Sci Rep.</i> 2015; <b>5</b>: 11990. <a target=xrefwindow id=d85322e2698 href="http://www.ncbi.nlm.nih.gov/pubmed/26189707">PubMed Abstract </a> | <a target=xrefwindow id=d85322e2701 href="http://dx.doi.org/10.1038/srep11990">Publisher Full Text </a> | <a target=xrefwindow id=d85322e2705 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4507173">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/725658681">F1000 Recommendation</a></span></li><li><a name=ref-67 class=n-a></a><span class=label>67. </span>&nbsp;<span class=citation><a name=d85322e2718 class=n-a></a>Murthy N, Robichaud JR, Tirrell DA, <i> et al.</i>: The design and synthesis of polymers for eukaryotic membrane disruption. <i>J Control Release.</i> 1999; <b>61</b>(1–2): 137–43. <a target=xrefwindow id=d85322e2729 href="http://www.ncbi.nlm.nih.gov/pubmed/10469910">PubMed Abstract </a> | <a target=xrefwindow id=d85322e2732 href="http://dx.doi.org/10.1016/S0168-3659(99)00114-5">Publisher Full Text </a></span></li><li><a name=ref-68 class=n-a></a><span class=label>68. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/726182989"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d85322e2741 class=n-a></a>Wang M, Zuris JA, Meng F, <i> et al.</i>: Efficient delivery of genome-editing proteins using bioreducible lipid nanoparticles. <i>Proc Natl Acad Sci U S A.</i> 2016; <b>113</b>(11): 2868–73. <a target=xrefwindow id=d85322e2752 href="http://www.ncbi.nlm.nih.gov/pubmed/26929348">PubMed Abstract </a> | <a target=xrefwindow id=d85322e2755 href="http://dx.doi.org/10.1073/pnas.1520244113">Publisher Full Text </a> | <a target=xrefwindow id=d85322e2759 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4801296">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/726182989">F1000 Recommendation</a></span></li><li><a name=ref-69 class=n-a></a><span class=label>69. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/726028045"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d85322e2772 class=n-a></a>Zuchero YJ, Chen X, Bien-Ly N, <i> et al.</i>: Discovery of Novel Blood-Brain Barrier Targets to Enhance Brain Uptake of Therapeutic Antibodies. <i>Neuron.</i> 2016; <b>89</b>(1): 70–82. <a target=xrefwindow id=d85322e2783 href="http://www.ncbi.nlm.nih.gov/pubmed/26687840">PubMed Abstract </a> | <a target=xrefwindow id=d85322e2786 href="http://dx.doi.org/10.1016/j.neuron.2015.11.024">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/726028045">F1000 Recommendation</a></span></li><li><a name=ref-70 class=n-a></a><span class=label>70. </span>&nbsp;<span class=citation><a name=d85322e2799 class=n-a></a>Frankel AD, Pabo CO: Cellular uptake of the tat protein from human immunodeficiency virus. <i>Cell.</i> 1988; <b>55</b>(6): 1189–93. <a target=xrefwindow id=d85322e2807 href="http://www.ncbi.nlm.nih.gov/pubmed/2849510">PubMed Abstract </a> | <a target=xrefwindow id=d85322e2810 href="http://dx.doi.org/10.1016/0092-8674(88)90263-2">Publisher Full Text </a></span></li><li><a name=ref-71 class=n-a></a><span class=label>71. </span>&nbsp;<span class=citation><a name=d85322e2819 class=n-a></a>Derossi D, Joliot AH, Chassaing G, <i> et al.</i>: The third helix of the Antennapedia homeodomain translocates through biological membranes. <i>J Biol Chem.</i> 1994; <b>269</b>(14): 10444–50. <a target=xrefwindow id=d85322e2830 href="http://www.ncbi.nlm.nih.gov/pubmed/8144628">PubMed Abstract </a></span></li><li><a name=ref-72 class=n-a></a><span class=label>72. </span>&nbsp;<span class=citation><a name=d85322e2840 class=n-a></a>Joliot A, Pernelle C, Deagostini-Bazin H, <i> et al.</i>: Antennapedia homeobox peptide regulates neural morphogenesis. <i>Proc Natl Acad Sci U S A.</i> 1991; <b>88</b>(5): 1864–8. <a target=xrefwindow id=d85322e2851 href="http://www.ncbi.nlm.nih.gov/pubmed/1672046">PubMed Abstract </a> | <a target=xrefwindow id=d85322e2854 href="http://www.ncbi.nlm.nih.gov/pmc/articles/51126">Free Full Text </a></span></li><li><a name=ref-73 class=n-a></a><span class=label>73. </span>&nbsp;<span class=citation><a name=d85322e2863 class=n-a></a>Chen BX, Erlanger BF: Intracellular delivery of monoclonal antibodies. <i>Immunol Lett.</i> 2002; <b>84</b>(1): 63–7. <a target=xrefwindow id=d85322e2871 href="http://www.ncbi.nlm.nih.gov/pubmed/12161285">PubMed Abstract </a> | <a target=xrefwindow id=d85322e2874 href="http://dx.doi.org/10.1016/S0165-2478(02)00146-3">Publisher Full Text </a></span></li><li><a name=ref-74 class=n-a></a><span class=label>74. </span>&nbsp;<span class=citation><a name=d85322e2883 class=n-a></a>Pooga M, Hällbrink M, Zorko M, <i> et al.</i>: Cell penetration by transportan. <i>FASEB J.</i> 1998; <b>12</b>(1): 67–77. <a target=xrefwindow id=d85322e2894 href="http://www.ncbi.nlm.nih.gov/pubmed/9438412">PubMed Abstract </a></span></li><li><a name=ref-75 class=n-a></a><span class=label>75. </span>&nbsp;<span class=citation><a name=d85322e2903 class=n-a></a>Kwon SJ, Han K, Jung S, <i> et al.</i>: Transduction of the MPG-tagged fusion protein into mammalian cells and oocytes depends on amiloride-sensitive endocytic pathway. <i>BMC Biotechnol.</i> 2009; <b>9</b>: 73. <a target=xrefwindow id=d85322e2914 href="http://www.ncbi.nlm.nih.gov/pubmed/19706197">PubMed Abstract </a> | <a target=xrefwindow id=d85322e2917 href="http://dx.doi.org/10.1186/1472-6750-9-73">Publisher Full Text </a> | <a target=xrefwindow id=d85322e2921 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2748071">Free Full Text </a></span></li><li><a name=ref-76 class=n-a></a><span class=label>76. </span>&nbsp;<span class=citation><a name=d85322e2930 class=n-a></a>Morris MC, Vidal P, Chaloin L, <i> et al.</i>: A new peptide vector for efficient delivery of oligonucleotides into mammalian cells. <i>Nucleic Acids Res.</i> 1997; <b>25</b>(14): 2730–6. <a target=xrefwindow id=d85322e2941 href="http://www.ncbi.nlm.nih.gov/pubmed/9207018">PubMed Abstract </a> | <a target=xrefwindow id=d85322e2944 href="http://dx.doi.org/10.1093/nar/25.14.2730">Publisher Full Text </a> | <a target=xrefwindow id=d85322e2948 href="http://www.ncbi.nlm.nih.gov/pmc/articles/146800">Free Full Text </a></span></li><li><a name=ref-77 class=n-a></a><span class=label>77. </span>&nbsp;<span class=citation><a name=d85322e2957 class=n-a></a>Oehlke J, Scheller A, Wiesner B, <i> et al.</i>: Cellular uptake of an alpha-helical amphipathic model peptide with the potential to deliver polar compounds into the cell interior non-endocytically. <i>Biochim Biophys Acta.</i> 1998; <b>1414</b>(1–2): 127–39. <a target=xrefwindow id=d85322e2968 href="http://www.ncbi.nlm.nih.gov/pubmed/9804921">PubMed Abstract </a> | <a target=xrefwindow id=d85322e2971 href="http://dx.doi.org/10.1016/S0005-2736(98)00161-8">Publisher Full Text </a></span></li><li><a name=ref-78 class=n-a></a><span class=label>78. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/1002987"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d85322e2981 class=n-a></a>Morris MC, Depollier J, Mery J, <i> et al.</i>: A peptide carrier for the delivery of biologically active proteins into mammalian cells. <i>Nat Biotechnol.</i> 2001; <b>19</b>(12): 1173–6. <a target=xrefwindow id=d85322e2992 href="http://www.ncbi.nlm.nih.gov/pubmed/11731788">PubMed Abstract </a> | <a target=xrefwindow id=d85322e2995 href="http://dx.doi.org/10.1038/nbt1201-1173">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/1002987">F1000 Recommendation</a></span></li><li><a name=ref-79 class=n-a></a><span class=label>79. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/725590959"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d85322e3008 class=n-a></a>Young Kim H, Young Yum S, Jang G, <i> et al.</i>: Discovery of a non-cationic cell penetrating peptide derived from membrane-interacting human proteins and its potential as a protein delivery carrier. <i>Sci Rep.</i> 2015; <b>5</b>: 11719. <a target=xrefwindow id=d85322e3019 href="http://www.ncbi.nlm.nih.gov/pubmed/26114640">PubMed Abstract </a> | <a target=xrefwindow id=d85322e3022 href="http://dx.doi.org/10.1038/srep11719">Publisher Full Text </a> | <a target=xrefwindow id=d85322e3026 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4481774">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/725590959">F1000 Recommendation</a></span></li><li><a name=ref-80 class=n-a></a><span class=label>80. </span>&nbsp;<span class=citation><a name=d85322e3039 class=n-a></a>Cao G, Pei W, Ge H, <i> et al.</i>: <i>In Vivo</i> Delivery of a Bcl-xL Fusion Protein Containing the TAT Protein Transduction Domain Protects against Ischemic Brain Injury and Neuronal Apoptosis. <i>J Neurosci.</i> 2002; <b>22</b>(13): 5423–31. <a target=xrefwindow id=d85322e3053 href="http://www.ncbi.nlm.nih.gov/pubmed/12097494">PubMed Abstract </a></span></li><li><a name=ref-81 class=n-a></a><span class=label>81. </span>&nbsp;<span class=citation><a name=d85322e3062 class=n-a></a>Fawell S, Seery J, Daikh Y, <i> et al.</i>: Tat-mediated delivery of heterologous proteins into cells. <i>Proc Natl Acad Sci U S A.</i> 1994; <b>91</b>(2): 664–8. <a target=xrefwindow id=d85322e3073 href="http://www.ncbi.nlm.nih.gov/pubmed/8290579">PubMed Abstract </a> | <a target=xrefwindow id=d85322e3076 href="http://dx.doi.org/10.1073/pnas.91.2.664">Publisher Full Text </a> | <a target=xrefwindow id=d85322e3080 href="http://www.ncbi.nlm.nih.gov/pmc/articles/43009">Free Full Text </a></span></li><li><a name=ref-82 class=n-a></a><span class=label>82. </span>&nbsp;<span class=citation><a name=d85322e3089 class=n-a></a>Hirt L, Badaut J, Thevenet J, <i> et al.</i>: D-JNKI1, a cell-penetrating c-Jun-N-terminal kinase inhibitor, protects against cell death in severe cerebral ischemia. <i>Stroke.</i> 2004; <b>35</b>(7): 1738–43. <a target=xrefwindow id=d85322e3100 href="http://www.ncbi.nlm.nih.gov/pubmed/15178829">PubMed Abstract </a> | <a target=xrefwindow id=d85322e3103 href="http://dx.doi.org/10.1161/01.STR.0000131480.03994.b1">Publisher Full Text </a></span></li><li><a name=ref-83 class=n-a></a><span class=label>83. </span>&nbsp;<span class=citation><a name=d85322e3112 class=n-a></a>Fu A, Wang Y, Zhan L, <i> et al.</i>: Targeted delivery of proteins into the central nervous system mediated by rabies virus glycoprotein-derived peptide. <i>Pharm Res.</i> 2012; <b>29</b>(6): 1562–9. <a target=xrefwindow id=d85322e3123 href="http://www.ncbi.nlm.nih.gov/pubmed/22231987">PubMed Abstract </a> | <a target=xrefwindow id=d85322e3126 href="http://dx.doi.org/10.1007/s11095-012-0667-y">Publisher Full Text </a></span></li><li><a name=ref-84 class=n-a></a><span class=label>84. </span>&nbsp;<span class=citation><a name=d85322e3136 class=n-a></a>Jo D, Liu D, Yao S, <i> et al.</i>: Intracellular protein therapy with SOCS3 inhibits inflammation and apoptosis. <i>Nat Med.</i> 2005; <b>11</b>(8): 892–8. <a target=xrefwindow id=d85322e3147 href="http://www.ncbi.nlm.nih.gov/pubmed/16007096">PubMed Abstract </a> | <a target=xrefwindow id=d85322e3150 href="http://dx.doi.org/10.1038/nm1269">Publisher Full Text </a></span></li><li><a name=ref-85 class=n-a></a><span class=label>85. </span>&nbsp;<span class=citation><a name=d85322e3159 class=n-a></a>Schwarze SR, Ho A, Vocero-Akbani A, <i> et al.</i>: <i>In vivo</i> protein transduction: delivery of a biologically active protein into the mouse. <i>Science.</i> 1999; <b>285</b>(5433): 1569–72. <a target=xrefwindow id=d85322e3173 href="http://www.ncbi.nlm.nih.gov/pubmed/10477521">PubMed Abstract </a> | <a target=xrefwindow id=d85322e3177 href="http://dx.doi.org/10.1126/science.285.5433.1569">Publisher Full Text </a></span></li><li><a name=ref-86 class=n-a></a><span class=label>86. </span>&nbsp;<span class=citation><a name=d85322e3186 class=n-a></a>Xiang L, Zhou R, Fu A, <i> et al.</i>: Targeted delivery of large fusion protein into hippocampal neurons by systemic administration. <i>J Drug Target.</i> 2011; <b>19</b>(8): 632–6. <a target=xrefwindow id=d85322e3197 href="http://www.ncbi.nlm.nih.gov/pubmed/20932231">PubMed Abstract </a> | <a target=xrefwindow id=d85322e3200 href="http://dx.doi.org/10.3109/1061186X.2010.523788">Publisher Full Text </a></span></li><li><a name=ref-87 class=n-a></a><span class=label>87. </span>&nbsp;<span class=citation><a name=d85322e3209 class=n-a></a>Leifert JA, Harkins S, Whitton JL: Full-length proteins attached to the HIV tat protein transduction domain are neither transduced between cells, nor exhibit enhanced immunogenicity. <i>Gene Ther.</i> 2002; <b>9</b>(21): 1422–8. <a target=xrefwindow id=d85322e3217 href="http://www.ncbi.nlm.nih.gov/pubmed/12378404">PubMed Abstract </a> | <a target=xrefwindow id=d85322e3220 href="http://dx.doi.org/10.1038/sj.gt.3301819">Publisher Full Text </a></span></li><li><a name=ref-88 class=n-a></a><span class=label>88. </span>&nbsp;<span class=citation><a name=d85322e3229 class=n-a></a>Lundberg M, Johansson M: Is VP22 nuclear homing an artifact? <i>Nat Biotechnol.</i> 2001; <b>19</b>(8): 713–4. <a target=xrefwindow id=d85322e3237 href="http://www.ncbi.nlm.nih.gov/pubmed/11479552">PubMed Abstract </a> | <a target=xrefwindow id=d85322e3240 href="http://dx.doi.org/10.1038/90741">Publisher Full Text </a></span></li><li><a name=ref-89 class=n-a></a><span class=label>89. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/1011095"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d85322e3249 class=n-a></a>Richard JP, Melikov K, Vives E, <i> et al.</i>: Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake. <i>J Biol Chem.</i> 2003; <b>278</b>(1): 585–90. <a target=xrefwindow id=d85322e3260 href="http://www.ncbi.nlm.nih.gov/pubmed/12411431">PubMed Abstract </a> | <a target=xrefwindow id=d85322e3263 href="http://dx.doi.org/10.1074/jbc.M209548200">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/1011095">F1000 Recommendation</a></span></li><li><a name=ref-90 class=n-a></a><span class=label>90. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/1017408"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d85322e3277 class=n-a></a>Wadia JS, Stan RV, Dowdy SF: Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. <i>Nat Med.</i> 2004; <b>10</b>(3): 310–5. <a target=xrefwindow id=d85322e3285 href="http://www.ncbi.nlm.nih.gov/pubmed/14770178">PubMed Abstract </a> | <a target=xrefwindow id=d85322e3288 href="http://dx.doi.org/10.1038/nm996">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/1017408">F1000 Recommendation</a></span></li><li><a name=ref-91 class=n-a></a><span class=label>91. </span>&nbsp;<span class=citation><a name=d85322e3301 class=n-a></a>Nakase I, Hirose H, Tanaka G, <i> et al.</i>: Cell-surface accumulation of flock house virus-derived peptide leads to efficient internalization via macropinocytosis. <i>Mol Ther.</i> 2009; <b>17</b>(11): 1868–76. <a target=xrefwindow id=d85322e3312 href="http://www.ncbi.nlm.nih.gov/pubmed/19707187">PubMed Abstract </a> | <a target=xrefwindow id=d85322e3315 href="http://dx.doi.org/10.1038/mt.2009.192">Publisher Full Text </a> | <a target=xrefwindow id=d85322e3319 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2835031">Free Full Text </a></span></li><li><a name=ref-92 class=n-a></a><span class=label>92. </span>&nbsp;<span class=citation><a name=d85322e3328 class=n-a></a>Khalil IA, Kogure K, Futaki S, <i> et al.</i>: High density of octaarginine stimulates macropinocytosis leading to efficient intracellular trafficking for gene expression. <i>J Biol Chem.</i> 2006; <b>281</b>(6): 3544–51. <a target=xrefwindow id=d85322e3339 href="http://www.ncbi.nlm.nih.gov/pubmed/16326716">PubMed Abstract </a> | <a target=xrefwindow id=d85322e3342 href="http://dx.doi.org/10.1074/jbc.M503202200">Publisher Full Text </a></span></li><li><a name=ref-93 class=n-a></a><span class=label>93. </span>&nbsp;<span class=citation><a name=d85322e3351 class=n-a></a>Räägel H, Säälik P, Pooga M: Peptide-mediated protein delivery-which pathways are penetrable? <i>Biochim Biophys Acta.</i> 2010; <b>1798</b>(12): 2240–8. <a target=xrefwindow id=d85322e3359 href="http://www.ncbi.nlm.nih.gov/pubmed/20170627">PubMed Abstract </a> | <a target=xrefwindow id=d85322e3362 href="http://dx.doi.org/10.1016/j.bbamem.2010.02.013">Publisher Full Text </a></span></li><li><a name=ref-94 class=n-a></a><span class=label>94. </span>&nbsp;<span class=citation><a name=d85322e3371 class=n-a></a>Fischer R, Köhler K, Fotin-Mleczek M, <i> et al.</i>: A stepwise dissection of the intracellular fate of cationic cell-penetrating peptides. <i>J Biol Chem.</i> 2004; <b>279</b>(13): 12625–35. <a target=xrefwindow id=d85322e3382 href="http://www.ncbi.nlm.nih.gov/pubmed/14707144">PubMed Abstract </a> | <a target=xrefwindow id=d85322e3385 href="http://dx.doi.org/10.1074/jbc.M311461200">Publisher Full Text </a></span></li><li><a name=ref-95 class=n-a></a><span class=label>95. </span>&nbsp;<span class=citation><a name=d85322e3394 class=n-a></a>Console S, Marty C, García-Echeverría C, <i> et al.</i>: Antennapedia and HIV transactivator of transcription (TAT) "protein transduction domains" promote endocytosis of high molecular weight cargo upon binding to cell surface glycosaminoglycans. <i>J Biol Chem.</i> 2003; <b>278</b>(37): 35109–14. <a target=xrefwindow id=d85322e3405 href="http://www.ncbi.nlm.nih.gov/pubmed/12837762">PubMed Abstract </a> | <a target=xrefwindow id=d85322e3408 href="http://dx.doi.org/10.1074/jbc.M301726200">Publisher Full Text </a></span></li><li><a name=ref-96 class=n-a></a><span class=label>96. </span>&nbsp;<span class=citation><a name=d85322e3418 class=n-a></a>Tünnemann G, Martin RM, Haupt S, <i> et al.</i>: Cargo-dependent mode of uptake and bioavailability of TAT-containing proteins and peptides in living cells. <i>FASEB J.</i> 2006; <b>20</b>(11): 1775–84. <a target=xrefwindow id=d85322e3429 href="http://www.ncbi.nlm.nih.gov/pubmed/16940149">PubMed Abstract </a> | <a target=xrefwindow id=d85322e3432 href="http://dx.doi.org/10.1096/fj.05-5523com">Publisher Full Text </a></span></li><li><a name=ref-97 class=n-a></a><span class=label>97. </span>&nbsp;<span class=citation><a name=d85322e3441 class=n-a></a>Säälik P, Elmquist A, Hansen M, <i> et al.</i>: Protein cargo delivery properties of cell-penetrating peptides. A comparative study. <i>Bioconjug Chem.</i> 2004; <b>15</b>(6): 1246–53. <a target=xrefwindow id=d85322e3452 href="http://www.ncbi.nlm.nih.gov/pubmed/15546190">PubMed Abstract </a> | <a target=xrefwindow id=d85322e3455 href="http://dx.doi.org/10.1021/bc049938y">Publisher Full Text </a></span></li><li><a name=ref-98 class=n-a></a><span class=label>98. </span>&nbsp;<span class=citation><a name=d85322e3464 class=n-a></a>Jiao CY, Delaroche D, Burlina F, <i> et al.</i>: Translocation and endocytosis for cell-penetrating peptide internalization. <i>J Biol Chem.</i> 2009; <b>284</b>(49): 33957–65. <a target=xrefwindow id=d85322e3475 href="http://www.ncbi.nlm.nih.gov/pubmed/19833724">PubMed Abstract </a> | <a target=xrefwindow id=d85322e3478 href="http://dx.doi.org/10.1074/jbc.M109.056309">Publisher Full Text </a> | <a target=xrefwindow id=d85322e3482 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2797166">Free Full Text </a></span></li><li><a name=ref-99 class=n-a></a><span class=label>99. </span>&nbsp;<span class=citation><a name=d85322e3491 class=n-a></a>Stalmans S, Bracke N, Wynendaele E, <i> et al.</i>: Cell-Penetrating Peptides Selectively Cross the Blood-Brain Barrier <i>In Vivo</i>. <i>PLoS One.</i> 2015; <b>10</b>(10): e0139652. <a target=xrefwindow id=d85322e3505 href="http://www.ncbi.nlm.nih.gov/pubmed/26465925">PubMed Abstract </a> | <a target=xrefwindow id=d85322e3509 href="http://dx.doi.org/10.1371/journal.pone.0139652">Publisher Full Text </a> | <a target=xrefwindow id=d85322e3512 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4605843">Free Full Text </a></span></li><li><a name=ref-100 class=n-a></a><span class=label>100. </span>&nbsp;<span class=citation><a name=d85322e3521 class=n-a></a>Grove J, Marsh M: The cell biology of receptor-mediated virus entry. <i>J Cell Biol.</i> 2011; <b>195</b>(7): 1071–82. <a target=xrefwindow id=d85322e3529 href="http://www.ncbi.nlm.nih.gov/pubmed/22123832">PubMed Abstract </a> | <a target=xrefwindow id=d85322e3532 href="http://dx.doi.org/10.1083/jcb.201108131">Publisher Full Text </a> | <a target=xrefwindow id=d85322e3535 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3246895">Free Full Text </a></span></li><li><a name=ref-101 class=n-a></a><span class=label>101. </span>&nbsp;<span class=citation><a name=d85322e3544 class=n-a></a>Barth H, Ulsenheimer A, Pape GR, <i> et al.</i>: Uptake and presentation of hepatitis C virus-like particles by human dendritic cells. <i>Blood.</i> 2005; <b>105</b>(9): 3605–14. <a target=xrefwindow id=d85322e3555 href="http://www.ncbi.nlm.nih.gov/pubmed/15657184">PubMed Abstract </a> | <a target=xrefwindow id=d85322e3558 href="http://dx.doi.org/10.1182/blood-2004-05-1952">Publisher Full Text </a></span></li><li><a name=ref-102 class=n-a></a><span class=label>102. </span>&nbsp;<span class=citation><a name=d85322e3568 class=n-a></a>Triyatni M, Saunier B, Maruvada P, <i> et al.</i>: Interaction of hepatitis C virus-like particles and cells: a model system for studying viral binding and entry. <i>J Virol.</i> 2002; <b>76</b>(18): 9335–44. <a target=xrefwindow id=d85322e3579 href="http://www.ncbi.nlm.nih.gov/pubmed/12186916">PubMed Abstract </a> | <a target=xrefwindow id=d85322e3582 href="http://dx.doi.org/10.1128/JVI.76.18.9335-9344.2002">Publisher Full Text </a> | <a target=xrefwindow id=d85322e3586 href="http://www.ncbi.nlm.nih.gov/pmc/articles/136469">Free Full Text </a></span></li><li><a name=ref-103 class=n-a></a><span class=label>103. </span>&nbsp;<span class=citation><a name=d85322e3595 class=n-a></a>Takamura S, Niikura M, Li TC, <i> et al.</i>: DNA vaccine-encapsulated virus-like particles derived from an orally transmissible virus stimulate mucosal and systemic immune responses by oral administration. <i>Gene Ther.</i> 2004; <b>11</b>(7): 628–35. <a target=xrefwindow id=d85322e3606 href="http://www.ncbi.nlm.nih.gov/pubmed/14973544">PubMed Abstract </a> | <a target=xrefwindow id=d85322e3609 href="http://dx.doi.org/10.1038/sj.gt.3302193">Publisher Full Text </a></span></li><li><a name=ref-104 class=n-a></a><span class=label>104. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/726562147"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d85322e3618 class=n-a></a>Jariyapong P, Chotwiwatthanakun C, Somrit M, <i> et al.</i>: Encapsulation and delivery of plasmid DNA by virus-like nanoparticles engineered from <i>Macrobrachium rosenbergii</i> nodavirus. <i>Virus Res.</i> 2014; <b>179</b>: 140–6. <a target=xrefwindow id=d85322e3632 href="http://www.ncbi.nlm.nih.gov/pubmed/24184445">PubMed Abstract </a> | <a target=xrefwindow id=d85322e3636 href="http://dx.doi.org/10.1016/j.virusres.2013.10.021">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/726562147">F1000 Recommendation</a></span></li><li><a name=ref-105 class=n-a></a><span class=label>105. </span>&nbsp;<span class=citation><a name=d85322e3649 class=n-a></a>Ashley CE, Carnes EC, Phillips GK, <i> et al.</i>: Cell-specific delivery of diverse cargos by bacteriophage MS2 virus-like particles. <i>ACS Nano.</i> 2011; <b>5</b>(7): 5729–45. <a target=xrefwindow id=d85322e3660 href="http://www.ncbi.nlm.nih.gov/pubmed/21615170">PubMed Abstract </a> | <a target=xrefwindow id=d85322e3663 href="http://dx.doi.org/10.1021/nn201397z">Publisher Full Text </a> | <a target=xrefwindow id=d85322e3667 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3144304">Free Full Text </a></span></li><li><a name=ref-106 class=n-a></a><span class=label>106. </span>&nbsp;<span class=citation><a name=d85322e3676 class=n-a></a>Lu X, Thompson JR, Perry KL: Encapsidation of DNA, a protein and a fluorophore into virus-like particles by the capsid protein of cucumber mosaic virus. <i>J Gen Virol.</i> 2012; <b>93</b>(Pt 5): 1120–6. <a target=xrefwindow id=d85322e3684 href="http://www.ncbi.nlm.nih.gov/pubmed/22278829">PubMed Abstract </a> | <a target=xrefwindow id=d85322e3687 href="http://dx.doi.org/10.1099/vir.0.040170-0">Publisher Full Text </a></span></li><li><a name=ref-107 class=n-a></a><span class=label>107. </span>&nbsp;<span class=citation><a name=d85322e3696 class=n-a></a>Lipin DI, Chuan YP, Lua LH, <i> et al.</i>: Encapsulation of DNA and non-viral protein changes the structure of murine polyomavirus virus-like particles. <i>Arch Virol.</i> 2008; <b>153</b>(11): 2027–39. <a target=xrefwindow id=d85322e3707 href="http://www.ncbi.nlm.nih.gov/pubmed/18979257">PubMed Abstract </a> | <a target=xrefwindow id=d85322e3710 href="http://dx.doi.org/10.1007/s00705-008-0220-9">Publisher Full Text </a></span></li><li><a name=ref-108 class=n-a></a><span class=label>108. </span>&nbsp;<span class=citation><a name=d85322e3720 class=n-a></a>Da Silva DM, Schiller JT, Kast WM: Heterologous boosting increases immunogenicity of chimeric papillomavirus virus-like particle vaccines. <i>Vaccine.</i> 2003; <b>21</b>(23): 3219–27. <a target=xrefwindow id=d85322e3728 href="http://www.ncbi.nlm.nih.gov/pubmed/12804851">PubMed Abstract </a> | <a target=xrefwindow id=d85322e3731 href="http://dx.doi.org/10.1016/S0264-410X(03)00237-8">Publisher Full Text </a></span></li><li><a name=ref-109 class=n-a></a><span class=label>109. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/726172408"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d85322e3740 class=n-a></a>Abraham A, Natraj U, Karande AA, <i> et al.</i>: Intracellular delivery of antibodies by chimeric Sesbania mosaic virus (SeMV) virus like particles. <i>Sci Rep.</i> 2016; <b>6</b>: 21803. <a target=xrefwindow id=d85322e3751 href="http://www.ncbi.nlm.nih.gov/pubmed/26905902">PubMed Abstract </a> | <a target=xrefwindow id=d85322e3754 href="http://dx.doi.org/10.1038/srep21803">Publisher Full Text </a> | <a target=xrefwindow id=d85322e3758 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4764859">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/726172408">F1000 Recommendation</a></span></li><li><a name=ref-110 class=n-a></a><span class=label>110. </span>&nbsp;<span class=citation><a name=d85322e3771 class=n-a></a>Peretti S, Schiavoni I, Pugliese K, <i> et al.</i>: Cell death induced by the herpes simplex virus-1 thymidine kinase delivered by human immunodeficiency virus-1-based virus-like particles. <i>Mol Ther.</i> 2005; <b>12</b>(6): 1185–96. <a target=xrefwindow id=d85322e3782 href="http://www.ncbi.nlm.nih.gov/pubmed/16095973">PubMed Abstract </a> | <a target=xrefwindow id=d85322e3785 href="http://dx.doi.org/10.1016/j.ymthe.2005.06.474">Publisher Full Text </a></span></li><li><a name=ref-111 class=n-a></a><span class=label>111. </span>&nbsp;<span class=citation><a name=d85322e3794 class=n-a></a>Deml L, Kratochwil G, Osterrieder N, <i> et al.</i>: Increased incorporation of chimeric human immunodeficiency virus type 1 gp120 proteins into Pr55<sup>gag</sup> virus-like particles by an Epstein-Barr virus gp220/350-derived transmembrane domain. <i>Virology.</i> 1997; <b>235</b>(1): 10–25. <a target=xrefwindow id=d85322e3808 href="http://www.ncbi.nlm.nih.gov/pubmed/9300033">PubMed Abstract </a> | <a target=xrefwindow id=d85322e3812 href="http://dx.doi.org/10.1006/viro.1997.8669">Publisher Full Text </a></span></li><li><a name=ref-112 class=n-a></a><span class=label>112. </span>&nbsp;<span class=citation><a name=d85322e3821 class=n-a></a>Paliard X, Liu Y, Wagner R, <i> et al.</i>: Priming of strong, broad, and long-lived HIV type 1 p55<sup>gag</sup>-specific CD8<sup>+</sup> cytotoxic T cells after administration of a virus-like particle vaccine in rhesus macaques. <i>AIDS Res Hum Retroviruses.</i> 2000; <b>16</b>(3): 273–82. <a target=xrefwindow id=d85322e3839 href="http://www.ncbi.nlm.nih.gov/pubmed/10710215">PubMed Abstract </a> | <a target=xrefwindow id=d85322e3842 href="http://dx.doi.org/10.1089/088922200309368">Publisher Full Text </a></span></li><li><a name=ref-113 class=n-a></a><span class=label>113. </span>&nbsp;<span class=citation><a name=d85322e3851 class=n-a></a>Abbing A, Blaschke UK, Grein S, <i> et al.</i>: Efficient intracellular delivery of a protein and a low molecular weight substance via recombinant polyomavirus-like particles. <i>J Biol Chem.</i> 2004; <b>279</b>(26): 27410–21. <a target=xrefwindow id=d85322e3862 href="http://www.ncbi.nlm.nih.gov/pubmed/15102846">PubMed Abstract </a> | <a target=xrefwindow id=d85322e3865 href="http://dx.doi.org/10.1074/jbc.M313612200">Publisher Full Text </a></span></li><li><a name=ref-114 class=n-a></a><span class=label>114. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/718482141"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d85322e3875 class=n-a></a>Wu D, Roth MJ: MLV based viral-like-particles for delivery of toxic proteins and nuclear transcription factors. <i>Biomaterials.</i> 2014; <b>35</b>(29): 8416–26. <a target=xrefwindow id=d85322e3883 href="http://www.ncbi.nlm.nih.gov/pubmed/24997480">PubMed Abstract </a> | <a target=xrefwindow id=d85322e3886 href="http://dx.doi.org/10.1016/j.biomaterials.2014.06.006">Publisher Full Text </a> | <a target=xrefwindow id=d85322e3889 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4139071">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/718482141">F1000 Recommendation</a></span></li><li><a name=ref-115 class=n-a></a><span class=label>115. </span>&nbsp;<span class=citation><a name=d85322e3902 class=n-a></a>Yu D, Amano C, Fukuda T, <i> et al.</i>: The specific delivery of proteins to human liver cells by engineered bio-nanocapsules. <i>FEBS J.</i> 2005; <b>272</b>(14): 3651–60. <a target=xrefwindow id=d85322e3913 href="http://www.ncbi.nlm.nih.gov/pubmed/16008564">PubMed Abstract </a> | <a target=xrefwindow id=d85322e3916 href="http://dx.doi.org/10.1111/j.1742-4658.2005.04790.x">Publisher Full Text </a></span></li><li><a name=ref-116 class=n-a></a><span class=label>116. </span>&nbsp;<span class=citation><a name=d85322e3925 class=n-a></a>Aoki T, Miyauchi K, Urano E, <i> et al.</i>: Protein transduction by pseudotyped lentivirus-like nanoparticles. <i>Gene Ther.</i> 2011; <b>18</b>(9): 936–41. <a target=xrefwindow id=d85322e3936 href="http://www.ncbi.nlm.nih.gov/pubmed/21451580">PubMed Abstract </a> | <a target=xrefwindow id=d85322e3939 href="http://dx.doi.org/10.1038/gt.2011.38">Publisher Full Text </a></span></li><li><a name=ref-117 class=n-a></a><span class=label>117. </span>&nbsp;<span class=citation><a name=d85322e3948 class=n-a></a>Link N, Aubel C, Kelm JM, <i> et al.</i>: Therapeutic protein transduction of mammalian cells and mice by nucleic acid-free lentiviral nanoparticles. <i>Nucleic Acids Res.</i> 2006; <b>34</b>(2): e16. <a target=xrefwindow id=d85322e3959 href="http://www.ncbi.nlm.nih.gov/pubmed/16449199">PubMed Abstract </a> | <a target=xrefwindow id=d85322e3962 href="http://dx.doi.org/10.1093/nar/gnj014">Publisher Full Text </a> | <a target=xrefwindow id=d85322e3966 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1356536">Free Full Text </a></span></li><li><a name=ref-118 class=n-a></a><span class=label>118. </span>&nbsp;<span class=citation><a name=d85322e3975 class=n-a></a>Voelkel C, Galla M, Maetzig T, <i> et al.</i>: Protein transduction from retroviral Gag precursors. <i>Proc Natl Acad Sci U S A.</i> 2010; <b>107</b>(17): 7805–10. <a target=xrefwindow id=d85322e3986 href="http://www.ncbi.nlm.nih.gov/pubmed/20385817">PubMed Abstract </a> | <a target=xrefwindow id=d85322e3989 href="http://dx.doi.org/10.1073/pnas.0914517107">Publisher Full Text </a> | <a target=xrefwindow id=d85322e3993 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2867892">Free Full Text </a></span></li><li><a name=ref-119 class=n-a></a><span class=label>119. </span>&nbsp;<span class=citation><a name=d85322e4002 class=n-a></a>Kondo Y, Fushikida K, Fujieda T, <i> et al.</i>: Efficient delivery of antibody into living cells using a novel HVJ envelope vector system. <i>J Immunol Methods.</i> 2008; <b>332</b>(1–2): 10–7. <a target=xrefwindow id=d85322e4013 href="http://www.ncbi.nlm.nih.gov/pubmed/18221753">PubMed Abstract </a> | <a target=xrefwindow id=d85322e4016 href="http://dx.doi.org/10.1016/j.jim.2007.12.008">Publisher Full Text </a></span></li><li><a name=ref-120 class=n-a></a><span class=label>120. </span>&nbsp;<span class=citation><a name=d85322e4026 class=n-a></a>Schneider-Schaulies J: Cellular receptors for viruses: links to tropism and pathogenesis. <i>J Gen Virol.</i> 2000; <b>81</b>(Pt 6): 1413–29. <a target=xrefwindow id=d85322e4034 href="http://www.ncbi.nlm.nih.gov/pubmed/10811925">PubMed Abstract </a> | <a target=xrefwindow id=d85322e4037 href="http://dx.doi.org/10.1099/0022-1317-81-6-1413">Publisher Full Text </a></span></li><li><a name=ref-121 class=n-a></a><span class=label>121. </span>&nbsp;<span class=citation><a name=d85322e4046 class=n-a></a>Gleiter S, Lilie H: Coupling of antibodies via protein Z on modified polyoma virus-like particles. <i>Protein Sci.</i> 2001; <b>10</b>(2): 434–44. <a target=xrefwindow id=d85322e4054 href="http://www.ncbi.nlm.nih.gov/pubmed/11266629">PubMed Abstract </a> | <a target=xrefwindow id=d85322e4057 href="http://dx.doi.org/10.1110/ps.31101">Publisher Full Text </a> | <a target=xrefwindow id=d85322e4060 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2373932">Free Full Text </a></span></li><li><a name=ref-122 class=n-a></a><span class=label>122. </span>&nbsp;<span class=citation><a name=d85322e4069 class=n-a></a>Stubenrauch K, Gleiter S, Brinkmann U, <i> et al.</i>: Conjugation of an antibody Fv fragment to a virus coat protein: cell-specific targeting of recombinant polyoma-virus-like particles. <i>Biochem J.</i> 2001; <b>356</b>(Pt 3): 867–73. <a target=xrefwindow id=d85322e4080 href="http://www.ncbi.nlm.nih.gov/pubmed/11389696">PubMed Abstract </a> | <a target=xrefwindow id=d85322e4083 href="http://dx.doi.org/10.1042/bj3560867">Publisher Full Text </a> | <a target=xrefwindow id=d85322e4087 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1221915">Free Full Text </a></span></li><li><a name=ref-123 class=n-a></a><span class=label>123. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/725538495"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d85322e4096 class=n-a></a>Kato T, Yui M, Deo VK, <i> et al.</i>: Development of <i>Rous sarcoma</i> Virus-like Particles Displaying hCC49 scFv for Specific Targeted Drug Delivery to Human Colon Carcinoma Cells. <i>Pharm Res.</i> 2015; <b>32</b>(11): 3699–707. <a target=xrefwindow id=d85322e4110 href="http://www.ncbi.nlm.nih.gov/pubmed/26047779">PubMed Abstract </a> | <a target=xrefwindow id=d85322e4114 href="http://dx.doi.org/10.1007/s11095-015-1730-2">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/725538495">F1000 Recommendation</a></span></li><li><a name=ref-124 class=n-a></a><span class=label>124. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/725331141"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d85322e4127 class=n-a></a>Deo VK, Kato T, Park EY: Chimeric virus-like particles made using GAG and M1 capsid proteins providing dual drug delivery and vaccination platform. <i>Mol Pharm.</i> 2015; <b>12</b>(3): 839–45. <a target=xrefwindow id=d85322e4135 href="http://www.ncbi.nlm.nih.gov/pubmed/25627427">PubMed Abstract </a> | <a target=xrefwindow id=d85322e4138 href="http://dx.doi.org/10.1021/mp500860x">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/725331141">F1000 Recommendation</a></span></li><li><a name=ref-125 class=n-a></a><span class=label>125. </span>&nbsp;<span class=citation><a name=d85322e4151 class=n-a></a>Kasuya T, Yamada T, Uyeda A, <i> et al.</i>: <i>In vivo</i> protein delivery to human liver-derived cells using hepatitis B virus envelope pre-S region. <i>J Biosci Bioeng.</i> 2008; <b>106</b>(1): 99–102. <a target=xrefwindow id=d85322e4165 href="http://www.ncbi.nlm.nih.gov/pubmed/18691539">PubMed Abstract </a> | <a target=xrefwindow id=d85322e4169 href="http://dx.doi.org/10.1263/jbb.106.99">Publisher Full Text </a></span></li><li><a name=ref-126 class=n-a></a><span class=label>126. </span>&nbsp;<span class=citation><a name=d85322e4179 class=n-a></a>Som A, Reuter A, Tew GN: Protein transduction domain mimics: the role of aromatic functionality. <i>Angew Chem Int Ed Engl.</i> 2012; <b>51</b>(4): 980–3. <a target=xrefwindow id=d85322e4187 href="http://www.ncbi.nlm.nih.gov/pubmed/22170788">PubMed Abstract </a> | <a target=xrefwindow id=d85322e4190 href="http://dx.doi.org/10.1002/anie.201104624">Publisher Full Text </a></span></li><li><a name=ref-127 class=n-a></a><span class=label>127. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/4571956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d85322e4199 class=n-a></a>Cronican JJ, Thompson DB, Beier KT, <i> et al.</i>: Potent delivery of functional proteins into Mammalian cells <i>in vitro</i> and <i>in vivo</i> using a supercharged protein. <i>ACS Chem Biol.</i> 2010; <b>5</b>(8): 747–52. <a target=xrefwindow id=d85322e4217 href="http://www.ncbi.nlm.nih.gov/pubmed/20545362">PubMed Abstract </a> | <a target=xrefwindow id=d85322e4220 href="http://dx.doi.org/10.1021/cb1001153">Publisher Full Text </a> | <a target=xrefwindow id=d85322e4223 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2924640">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/4571956">F1000 Recommendation</a></span></li><li><a name=ref-128 class=n-a></a><span class=label>128. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/718887595"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d85322e4236 class=n-a></a>Liao X, Rabideau AE, Pentelute BL: Delivery of antibody mimics into mammalian cells via anthrax toxin protective antigen. <i>Chembiochem.</i> 2014; <b>15</b>(16): 2458–66. <a target=xrefwindow id=d85322e4244 href="http://www.ncbi.nlm.nih.gov/pubmed/25250705">PubMed Abstract </a> | <a target=xrefwindow id=d85322e4247 href="http://dx.doi.org/10.1002/cbic.201402290">Publisher Full Text </a> | <a target=xrefwindow id=d85322e4250 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4498471">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/718887595">F1000 Recommendation</a></span></li><li><a name=ref-129 class=n-a></a><span class=label>129. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/718453419"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d85322e4263 class=n-a></a>Gaj T, Liu J, Anderson KE, <i> et al.</i>: Protein delivery using Cys<sub>2</sub>-His<sub>2</sub> zinc-finger domains. <i>ACS Chem Biol.</i> 2014; <b>9</b>(8): 1662–7. <a target=xrefwindow id=d85322e4281 href="http://www.ncbi.nlm.nih.gov/pubmed/24936957">PubMed Abstract </a> | <a target=xrefwindow id=d85322e4284 href="http://dx.doi.org/10.1021/cb500282g">Publisher Full Text </a> | <a target=xrefwindow id=d85322e4287 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4519095">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/718453419">F1000 Recommendation</a></span></li><li><a name=ref-130 class=n-a></a><span class=label>130. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/725367185"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d85322e4300 class=n-a></a>Lorenzer C, Dirin M, Winkler AM, <i> et al.</i>: Going beyond the liver: progress and challenges of targeted delivery of siRNA therapeutics. <i>J Control Release.</i> 2015; <b>203</b>: 1–15. <a target=xrefwindow id=d85322e4311 href="http://www.ncbi.nlm.nih.gov/pubmed/25660205">PubMed Abstract </a> | <a target=xrefwindow id=d85322e4314 href="http://dx.doi.org/10.1016/j.jconrel.2015.02.003">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/725367185">F1000 Recommendation</a></span></li><li><a name=ref-131 class=n-a></a><span class=label>131. </span>&nbsp;<span class=citation><a name=d85322e4327 class=n-a></a>Pisal DS, Kosloski MP, Balu-Iyer SV: Delivery of therapeutic proteins. <i>J Pharm Sci.</i> 2010; <b>99</b>(6): 2557–75. <a target=xrefwindow id=d85322e4335 href="http://www.ncbi.nlm.nih.gov/pubmed/20049941">PubMed Abstract </a> | <a target=xrefwindow id=d85322e4338 href="http://dx.doi.org/10.1002/jps.22054">Publisher Full Text </a> | <a target=xrefwindow id=d85322e4341 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2857543">Free Full Text </a></span></li><li><a name=ref-132 class=n-a></a><span class=label>132. </span>&nbsp;<span class=citation><a name=d85322e4351 class=n-a></a>Varkouhi AK, Scholte M, Storm G, <i> et al.</i>: Endosomal escape pathways for delivery of biologicals. <i>J Control Release.</i> 2011; <b>151</b>(3): 220–8. <a target=xrefwindow id=d85322e4362 href="http://www.ncbi.nlm.nih.gov/pubmed/21078351">PubMed Abstract </a> | <a target=xrefwindow id=d85322e4365 href="http://dx.doi.org/10.1016/j.jconrel.2010.11.004">Publisher Full Text </a></span></li><li><a name=ref-133 class=n-a></a><span class=label>133. </span>&nbsp;<span class=citation><a name=d85322e4374 class=n-a></a>Rajendran L, Knölker HJ, Simons K: Subcellular targeting strategies for drug design and delivery. <i>Nat Rev Drug Discov.</i> 2010; <b>9</b>(1): 29–42. <a target=xrefwindow id=d85322e4382 href="http://www.ncbi.nlm.nih.gov/pubmed/20043027">PubMed Abstract </a> | <a target=xrefwindow id=d85322e4385 href="http://dx.doi.org/10.1038/nrd2897">Publisher Full Text </a></span></li><li><a name=ref-134 class=n-a></a><span class=label>134. </span>&nbsp;<span class=citation><a name=d85322e4394 class=n-a></a>Del Gaizo V, Payne RM: A novel TAT-mitochondrial signal sequence fusion protein is processed, stays in mitochondria, and crosses the placenta. <i>Mol Ther.</i> 2003; <b>7</b>(6): 720–30. <a target=xrefwindow id=d85322e4402 href="http://www.ncbi.nlm.nih.gov/pubmed/12788645">PubMed Abstract </a> | <a target=xrefwindow id=d85322e4405 href="http://dx.doi.org/10.1016/S1525-0016(03)00130-8">Publisher Full Text </a></span></li><li><a name=ref-135 class=n-a></a><span class=label>135. </span>&nbsp;<span class=citation><a name=d85322e4414 class=n-a></a>Mandal K, Uppalapati M, Ault-Riché D, <i> et al.</i>: Chemical synthesis and X-ray structure of a heterochiral {D-protein antagonist <i>plus</i> vascular endothelial growth factor} protein complex by racemic crystallography. <i>Proc Natl Acad Sci U S A.</i> 2012; <b>109</b>(37): 14779–84. <a target=xrefwindow id=d85322e4428 href="http://www.ncbi.nlm.nih.gov/pubmed/22927390">PubMed Abstract </a> | <a target=xrefwindow id=d85322e4432 href="http://dx.doi.org/10.1073/pnas.1210483109">Publisher Full Text </a> | <a target=xrefwindow id=d85322e4435 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3443191">Free Full Text </a></span></li><li><a name=ref-136 class=n-a></a><span class=label>136. </span>&nbsp;<span class=citation><a name=d85322e4444 class=n-a></a>Uppalapati M, Lee DJ, Mandal K, <i> et al.</i>: A Potent d-Protein Antagonist of VEGF-A is Nonimmunogenic, Metabolically Stable, and Longer-Circulating <i>in Vivo</i>. <i>ACS Chem Biol.</i> 2016; <b>11</b>(4): 1058–65. <a target=xrefwindow id=d85322e4458 href="http://www.ncbi.nlm.nih.gov/pubmed/26745345">PubMed Abstract </a> | <a target=xrefwindow id=d85322e4462 href="http://dx.doi.org/10.1021/acschembio.5b01006">Publisher Full Text </a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 10 Aug 2016</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/5-1947&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/5-1947&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> Banting and Best Department of Medical Research, Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, Ontario, Canada<br/> <p> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/5-1947/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 10 Aug 2016, 5:1947 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.8915.1">https://doi.org/10.12688/f1000research.8915.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> © 2016 Miersch S and Sidhu SS. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=9593 data-id=8915 data-downloads="" data-views="" data-scholar="10.12688/f1000research.8915.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/5-1947/v1/pdf?article_uuid=f4d4189a-2e0b-42dd-a942-5c4ae6e6ba25" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.8915.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Miersch S and Sidhu SS. Intracellular targeting with engineered proteins [version 1; peer review: 2 approved] <i>F1000Research</i> 2016, <b>5</b>(F1000 Faculty Rev):1947 (<a href="https://doi.org/10.12688/f1000research.8915.1" target=_blank>https://doi.org/10.12688/f1000research.8915.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=8915 id=mobile-track-article-signin-8915 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/8915?target=/articles/5-1947"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=9593 /> <input name=articleId type=hidden value=8915 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Daniel Christ</strong>, Garvan Institute of Medical Research, Australia </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Hirohide Saito</strong>, Department of Life Science Frontiers; Center for iPS Cell Research and Application, Kyoto University, Japan </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 10 Aug 2016</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/5-1947&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/5-1947&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=15636-14982></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=15637-14981></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=2><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/5-1947/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>10 Aug 16</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Daniel Christ</strong>, Garvan Institute of Medical Research, Australia </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Hirohide Saito</strong>, Department of Life Science Frontiers; Center for iPS Cell Research and Application, Kyoto University, Japan </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/5-1947&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/5-1947/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Intracellular targeting with engineered proteins".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/5-1947/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/5-1947/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/5-1947/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Miersch S and Sidhu SS');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/5-1947/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/5-1947",
            templates : {
                twitter : "Intracellular targeting with engineered proteins. Miersch S and Sidhu SS, published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/5-1947/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Intracellular targeting with engineered proteins", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Intracellular targeting with engineered proteins", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/8915/9593")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "9593");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "14981": 0,
                           "14982": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "6012bb9b-ba3a-407b-96e5-a699eb4ede20";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/5-1947.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/5-1947.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/5-1947.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/5-1947.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/5-1947.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>